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COMPARING HEALTH CONSEQUENCES OF P-HYDROXYBENZOIC ACID 
ESTERS (PARABENS) AND OTHER PRESERVATIVES IN THE 
ENVIRONMENT 
 
ELIZABETH A. READER 
 
ABSTRACT 
 
 
Parabens have been used as antimicrobial preservatives in multiple 
different types of products for decades, however relatively recent studies have 
caused concern as to whether their wide-use could be potentially harmful. The 
following paper reviews the extensive areas of human exposure, from mother to 
fetus, infants via breast milk, baby and child care products through adult personal 
care products, and other environmental sources. The potential impacts on human 
health are also discussed. Parabens predominantly impact biological systems as 
an endocrine disruptor not only by binding to the human Estrogen Receptor 
directly, but increasing the availability of naturally occurring 17β-estradiol, further 
potentiating the effect. 
Alternative antimicrobial preservatives are also discussed, along with their 
efficacies and potential health concerns. Common alternatives found in personal 
care products include phenoxyethanol, methylisothiazolinone, and formaldehyde 
releasers. Additionally, weak organic acids and plant-derived essential oils are 
also used in personal care products, but tend to be added more so to food 
vii 
 
products to prevent the growth of spoilage bacteria, fungi and mold. The potential 
for these alternatives to replace the use of parabens in personal care products, 
our greatest area of exposure, is very promising. If parabens in personal care 
products were replaced with a safe and effective alternative, then the other areas 
of environmental exposure would likely be negligible to produce any harm on 
society. Future investigation into the nuances of the various plant-derived 
essential oils and effective formulations for preservation, is likely the most 
promising solution, due to their mostly harmless nature. Lastly, the discussion of 
proposed future research in order to lead to a more definitive connection 
between paraben exposure and adverse health effects is presented. 
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INTRODUCTION 
 
 Para-hydroxybenzoic acid (PHBA) when combined with an alcohol, results 
in esters frequently referred to as parabens, which are widely used in 
pharmaceuticals, cosmetics, toiletries and food, as an antimicrobial agent due to 
their biocidal properties (Le Coz & Lepoittevin, 2007). Most commonly used are 
methyl-, ethyl-, propyl-, and butyl-parabens, which the Cosmetic Ingredient 
Review restricted to concentrations up to 25% in cosmetics in 1984 (Figure 1) 
(U.S. Food and Drug Administration, 2007).  
 
 
Figure 1 – Paraben chemical structure. R = alkyl chains that are methyl (CH3) for 
Methylparaben, ethyl (C2H5) for Ethylparaben, propyl (C3H7) for Propylparaben, and butyl 
(C4H9) for Butylparaben. Figure taken from Cosmetic Ingredient Review Expert Panel 
(CIR), 2008. 
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Though these agents have been used for more than 70 years, controversy 
remains as to whether they are safe for use in products that are ingested or 
applied to the skin, as they have shown adverse effects in various physiological 
realms (Cashman & Warshaw, 2005). In fact, the Cosmetic Ingredient Review 
reduced the allowable concentrations in cosmetics from 25% in 1984 to 0.4% for 
a single paraben and 0.8% for a mixture by 2008 (CIR, 2008), while more recent 
suggestions from the Scientific Committee on Consumer Safety of the European 
Union, reduced the singular concentration limit of butyl- and propyl-parabens to 
0.19% (Harvey & Everett, 2012). It is understandable that these agencies are 
becoming more cautious about the use of these chemicals, as more evidence to 
their potential harm is continually revealed.  
Despite countless articles portraying the negative effects of parabens, 
official data reviews conclude that they are safe to use as a preservatives due to 
the very low concentrations that are typically found in cosmetics and other 
products (CIR, 2008). Even though concerning data repeatedly surfaces, we 
continually ingest and topically apply parabens on a daily basis.  
SPECIFIC AIMS AND OBJECTIVES 
The following review aims to outline the current information regarding 
areas and levels of exposure, as well as the potential health effects of parabens 
to date. Additionally, some of the potential alternatives will be outlined and 
compared to parabens for preservation use. Lastly, proposals for future research 
to help guide the community to a consensus on the matter, shall be discussed. 
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PRESENTATION OF PUBLISHED LITERATURE 
Parabens 
Environmental Exposure 
Personal Care Products 
Guo et al., (2013) obtained 170 Personal Care Products (PCPs), including 
20 baby care products, from Albany, New York, U.S., and found parabens in 
about 40% of the rinse-off products and about 60% in the leave-on products, with 
the highest concentrations on the order of 1000 μg per gram of product. Total 
dermal intake was calculated to be 31.0 μg/kg body weight per day for adult 
females, however the calculated exposure for infants and toddlers was found to 
be 3 times higher at 58.6 to 766 μg/kg body weight per day (Guo, 2013). Though 
examining a smaller sample size (n = 52), Guo et al., (2014) performed the same 
analysis on products obtained in Tianjin, China. Methyl- and propylparaben 
dominated the field, being present in about 75% of the samples and had 
maximum concentrations of 2,826 and 1,564 μg/g, respectively (Guo, 2014). The 
authors estimated the total paraben median exposure dose to be 18,700 μg/d, 
(10,200 μg from methylparaben and 4,890 μg from propylparaben), with hand 
and body lotions being the main contributors (Guo, 2014). 
More than one paraben is typically used in PCPs, and Uter et al. (2014) 
utilized a survey of 4,680 products obtained between 2006 – 2009 in Germany, 
to examine the co-occurrence of these preservatives, outlined in Figure 2.  
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Figure 2 – Venn diagram of paraben occurrence in analysis of 4,680 personal 
care products in Germany from 2006 to 2009. Figure taken from Uter et al., 2014.  
 
Fetal/Infant 
 
Given the widespread use and existence of parabens in the environment, 
multiple studies have examined the correlation between maternal urine 
concentration of parabens and that of their unborn or recently delivered child. 
Fourty-six Korean women had the methyl-, ethyl-, propyl- and butylparaben 
concentrations measured in their urine, along with that of their newborn child 
(<48 hours after delivery), and a significant correlation of the two concentrations 
was seen (Kang, 2013). These findings are not limited to the region, as the 
National Children’s Study (NCS) Vanguard Study surveyed 506 pregnant women 
in the U.S. and determined that 100% of their urine samples contained 
methylparaben (Mortensen, 2014). An analysis of 200 Danish, pregnant women 
for urinary paraben concentration, was found that 95% of participants had at 
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least one paraben, with the majority of the samples containing methyl-, ethyl- and 
propylparabens, and the occurrence of methyl- and propylparabens were 
significantly correlated (Tefre de Renzy-Martin, 2014).  
In order to validate whether urinary parabens of the mother indeed are 
passed to the unborn infant, Philippat et al., (2013), leveraged seventy-one 
pregnant women who were referred for amniocentesis. They measured the 
paraben concentration of the amniotic fluid and compared it to urine samples 
obtained from the mothers, and found that propylparaben was present in more 
than 50% of the amniotic fluid samples (Phlilppat, 2013). Additionally, when the 
concentration of the amniotic fluid samples was analyzed against the mother’s 
urine concentration, there was a statistically significant positive correlation 
between the two (Philippat, 2013).  Further confirming the fact that the paraben 
exposure of pregnant women exposes their unborn child, 50 patients had their 
blood drawn upon hospital admission and a cord blood sample was obtained 
upon delivery of their child (Towers, 2014). Fourty-seven (94%) of the mother’s 
blood samples had methylparaben present, with a mean concentration of 20.41 
ng/L, while 47 (94%) of the cord blood samples, also contained methylparaben, 
but with a mean concentration of 36.54 ng/L (Towers, 2014). Though the 
umbilical cord blood had a higher concentration of methylparaben, it was not 
statistically significant (Towers, 2014). Additionally, the authors found that 
butylparaben additionally passed into the cord blood, however very few 
mother/cord samples tested positive for this paraben (Towers, 2014). 
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Schlumpf et al., (2010) analyzed human breast milk from 54 mothers who 
had just given birth at University Women’s Hospital Basel in Switzerland, over the 
course of three years from 2004 to 2006. Butylparaben was not found in any 
sample, however concentrations of methyl-, (2.18 ± 2.02 ng/mL), ethyl-, (1.26 ± 
0.23 ng/mL), and propylparaben, (1.42 ± 0.38 ng/mL), were detected in 15-34% 
of the milk samples, and the authors calculated the estimated daily paraben 
intake via milk ingestion, as shown in Table 1 (Schlumpf, 2010). 
In a more recent analysis, methyl-, ethyl-, propyl- and butylparabens were 
found in varying concentrations across 10 human breast milk samples collected 
in Granada, Spain (Rodriguez-Gómez, 2014). Eighty percent of the samples 
contained methyl- and butylparaben, with concentrations ranging from 0.9 to 11.3 
ng/mL, and 0.6 to 11.3 ng/mL, respectively (Rodrigues-Gómez, 2014). 
Ethylparaben was confirmed in six samples spanning concentrations of 0.5 to 
13.2 ng/mL, however propylparaben was the major compound found in 9/10 of 
the samples and had a relatively higher concentration range of 0.5 to 37.0 ng/mL 
(Rodrigues-Gómez, 2014).  
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Table 1 - Estimated Daily Intake via breast milk 
 Mean ± SD* 
N positive/N 
total 
Median* Range* 
Methyl-paraben 422.4 ± 376.8 14/41 192.5 161.4–1314.9 
Ethyl-paraben 223.7 ± 76.7 8/41 219.4 137.3–381.1 
Propyl-paraben 277.6 ± 91.8 6/41 301.3 132.7–381.1 
*Of positive samples 
 
Daily intake derived from human breast milk samples from new mothers at 
University Women’s Hospital Basel in Switzerland (ng/kg body weight (bw) per 
day). Adapted from Schlumph et al., 2010. 
 
Paper 
The examination of 253 paper products revealed that 98% contained at 
least one of the six most common parabens, ranging in concentration from 1.85 
to 3,220,000 ng/g, with a median of 55.1 ng/g (Liao, 2014). Methyl- and 
propylparaben dominated the spectrum, accounting for approximately 62% and 
16%, respectively, of that found in the sample, which included flyers, business 
cards, tickets, food cartons, paper currencies and newspapers (Liao, 2014). 
Authors calculated the estimated daily intake of parabens through dermal 
absorption by way of these paper products, between 6.31 and 2050 ng/day (95th 
percentiles), with sanitary wipes contributing the vast majority of the estimated 
exposure (Liao, 2014).  
Indoor Air/Dust 
In 2003, published data shared that methyl-, ethyl- and butylparabens 
were found in both air and dust samples from inside 120 homes in Cape Cod, 
Massachusetts, with methylparaben leading 67% of the 24-hour collection 
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samples with a median concentration of 978 ng/g (Rudel, 2003). Canosa et al., 
(2007) established the presence of methyl-, ethyl-, propyl- and butylparaben 
within indoor air samples, via new detection techniques. Indoor dust samples (n = 
158) were collected from the U.S., China, Korea and Japan and evaluated for the 
presence of six parabens and their common metabolite, 4-hydroxybenzoic acid 
(PHBA), (Wang, 2012). All samples contained the sought-after products, with 
methylparaben (226 – 1670 ng/g) and propylparaben (123 – 761 ng/g) being 
most popular, and the geometric means for each country’s dust sample in 
decreasing order were: Korea (2320 ng/g) > Japan (2300 ng/g) > U.S. (1390 
ng/g) > China (418 ng/g) (Wang, 2012). 
Wastewater/Sewage/Sludge 
When evaluating the wastewater via treatment plants surrounding Paris, 
France, there was a predominance of parabens in the samples, with 
concentrations ranging from 10,300 to 20,100 ng/g for methylparaben, 2,670 to 
4,670 ng/g for ethylparaben, 2,440 to 3,980 ng/g for propylparaben, and 
intermediate to low levels of butyl- and isobutylparaben, at 450 to 1280 ng/g and 
98 to 230 ng/g, respectively (Gasperi, 2014). Methylparaben maintained the 
highest concentration in that which was assessed, and accounted for 66% of the 
total parabens in the samples, while ethyl- and propylparaben represented 15%, 
and butyl- and isobutylparabens accounted for less than 4% (Gasperi, 2014).  
Sewage sludge from various wastewater treatment plants in Korea, along 
with sediment samples from various locations in the U.S., Japan and Korea, were 
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analyzed for paraben concentrations (Liao, 2013a). Methylparaben at 
concentrations ranging from 0.312 to 540 ng/g dry weight, was found in all 
samples, while propylparaben with concentrations 1 to 2 orders of magnitude 
lower than that of methylparaben, was found in 79% of the samples (Liao, 
2013a). 
Reservoirs/Surface Water 
Groundwater and reservoir samples were taken from the area around two 
municipal landfills outside of the city of Guangzhou, South China (Peng, 2014). 
Methylparaben lead the paraben spectrum amongst the groundwater samples, 
however reservoirs were found to be more contaminated with higher paraben 
incidence and measured concentrations (Peng, 2014). Measurements taken over 
the course of the year and with varying distances from the landfills, found no 
spatial or seasonal trends for the groundwater, however reservoir concentrations 
displayed higher paraben concentrations in the spring, and an overall decrease 
in concentration as sample locations moved away from landfill sites (Peng, 
2014). Comparable experiments across varying regions of the world have found 
parabens with diverse concentrations, as seen in Table 2 (Błędzka, 2014).  
Soil/Food 
Soil samples collected from various sites around Spain, had 
methylparaben and butylparaben in most samples, with concentrations ranging 
from 1.21 to 8.04 ng/g and 0.48 to 1.02 ng/g, respectively, (Pérez, 2012). Given 
that sewer sludge is often used to fertilize farmland, and that there is runoff from 
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landfills and wastewater treatment plants into the soil, scientists in Ontario, 
Canada examined the uptake of organic micro-pollutants into vegetables grown  
under these conditions (Sabourin, 2012). Tomatoes, carrots, potatoes and sweet 
corn were grown under the farming regulations in Ontario, which includes a 
mandated one-year offset between biosolid fertilization and the harvest of crops 
for human consumption (Sabourin, 2012). At the time of harvest, 7.14 ng of 
methylparaben was found in one gram of soil, however there were no detectable 
amounts in the grown vegetables (Sabourin, 2012).  
 
 
Table 2 – Summary of paraben concentrations in water samples. 
 
River and estuary water sample measurements of methyl-, ethyl-, propyl-, and 
butylparaben (ng/L) are summarized from different studies. Table taken from 
Błędzka et al., 2014.  
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Thirteen categories of food samples (n=282) including cereals, meat, fish 
and seafood, eggs, dairy products, bean products, fruits, vegetables, 
condiments, etc. were collected in nine cities in China, and examined for the 
concentration of six parabens (Liao, 2013b). At least one paraben was found in 
all (99%) of the samples and the cumulative mean of all parabens was 
determined to be 39.3 ng/g, with methyl- (59%), ethyl- (24%) and propylparaben 
(10%) being found to be the major parabens present (Liao, 2013b). The authors 
estimated the daily intake of parabens based upon their findings and daily food 
ingestion rates, as between 1,010 and 3,040 ng/kg (bw) per day for adult men, 
and 1,060 and 3,170 ng/kg (bw) per day for adult women (Liao, 2013b). These 
same authors performed a similar study by examining 267 food samples 
collected in Albany, NY, U.S., and determined that more than 90% of the 
samples had at least one paraben with a mean of 9.67 ng/g (Liao, 2013c). The 
estimated daily intakes were calculated for infants, toddlers, children, teenagers 
and adults, and were found to be 940, 879, 470, 273 and 307 ng/kg (bw) per day, 
respectively (Liao, 2013c).  
Fussell et al., (2014) collected 400 samples of food commodities in the 
United Kingdom, including mushrooms, vegetables, aquaculture products and 
animal tissues, as well as aquaculture products that were imported from 
Southeast Asia. Twenty-three samples of trout from the UK were found to have 
0.6 to 2.8 ng/g of methylparaben, and 19 samples contained 0.4 to 1.4 ng/g of 
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propylparaben, while imported fish and shrimp were discovered to have even 
lower concentrations (Fussell, 2014). 
Potential Health Effects 
Hormonal 
Estrogen Receptor 
Molecular modeling studies confirm that parabens can place their phenolic 
hydroxyl group in a similar position to 17β-estradiol’s (E2) 3-hydroxyl group in the 
human estrogen receptor, therefore bonding to Glu353, Arg394 and one water 
molecule (Byford, 2002). Taking a closer look at the binding conformation, all 
examined parabens (alkyl groups = 1-10) showed stable interaction energies 
when bonded to the ligand site (Byford, 2002). Additionally, smaller parabens 
(alkyl groups = 1-4) are able to pair-up, filling the entire binding site with the 
second paraben’s phenolic hydroxyl group bonded to His524, again with stable 
interaction energy, as shown in Table 3 (Byford, 2002).  
All of the most common parabens, (methyl-, ethyl-, propyl-, butyl-, and 
benzylparaben), have been found to bind antagonistically to human estrogen-
related receptor γ (ERRγ), to almost the same extent as the well-known 
estrogen-receptor antagonist, Bisphenol-A (Zhang, 2013). The authors 
additionally performed automated nuclear docking to reveal that all the tested 
parabens fit well into the activation site of ERRγ. Even more concerning is the 
fact that the concentration of receptors used in the above study was well below 
the level found in the human body, therefore the estrogenic potential en vivo is 
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likely to be much greater (Zhang, 2013). ERRγ is known as a constitutive gene 
regulator, therefore can activate transcription in the absence of ligands and 
remain “on” (Hong, 1999; Xie, 1999). 
The analysis of the effects of multiple androgen receptor antagonists from 
a wide range of sources was tested for activity in the breast cancer cell line, 
MDA-kb2. Some of the known receptor antagonists had higher levels of 
activation, as expected, however those that typically only cause activity at very 
high concentrations, showed additive effects when used in combination even at 
the typical lower concentrations, including parabens (Orton, 2014). 
 
Table 3 – Interaction energies for paraben binding with human estrogen receptor 
 
Parabens with alkyl chain lengths from 1 to 10, all release energy when binding, 
and those with alkyl chains of 1 to 4, can pair-up to bind with the estrogen 
receptor and release even more energy than alone. Table from Byford et al., 
2002. 
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Estrogenic Activity 
The morphogenesis of uteri cells when exposed to (methyl-, ethyl-, propyl- 
and butyl-) parabens versus E2, was evaluated using adult ovariectomized CD1 
mice treated daily with differing concentrations, over the course of three days 
(Lemini, 2004). Uterotrophic effects were seen at 38 to 76% of that of E2 (100% 
effect at 10 mg/kg) at the maximum tested concentrations of methyl- (165 
mg/kg), ethyl- (180 mg/kg), propyl- (195 mg/kg) and butylparaben (210 mg/kg), 
as measured by luminal epithelium heights, glandular epithelium heights, and 
myometrium widths (Lemini, 2004). All parabens at 362 mmol/kg of body weight 
induced substantial increases of uterine weight, with 1086 mmol/kg nearly 
doubling the uterine weight compared to control (Lemini, 2004). 
Utilizing a human cervical epithelioid carcinoma (HeLa) cell line 
transfected with ERR to produce HELN cells, Gomez et al., (2005) compared the 
effect of PHBA, (paraben’s carboxylase-produced metabolite), methyl-, ethyl-, 
propyl-, and butyl paraben esters on estrogenic activity. The authors used HELN 
cells, as a whole, to define nonspecific responses, and HELN ERRα and HELN 
ERRβ were employed in order to compare ERRα and ERRβ activity for each 
paraben studied (Gomez, 2005). It was discovered that methylparaben showed 
no activity up to 10−5 M, and that estrogenic activity toward ERRα and ERRβ 
increased with increasing alkyl chain length (Gomez, 2005). Of the tested 
chemicals, butylparaben was found to be the most active on ERRα and ERRβ, 
however was 105-fold less potent than the result of E2 (Gomez, 2005). 
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Watanabe et al., (2013) compared the transcriptional activation of human 
estrogen receptor α and β, between seventeen different parabens, however 
utilizing Chinese hamster ovary (CHO-K1) cells, as oppose to human estrogenic 
cells. The authors found that heptylparaben, with linear alkyl chain of C7, 
demonstrated the most significant estrogenic activity via ERRα, while 
pentylparaben, with linear alkyl chain C5, was the most potent by the means of 
ERRβ (Watanabe, 2013). Transcriptional activity decreased sequentially in 
parabens with shorter chains and longer chains, relative to heptyl- and 
pentylparaben (Watanabe, 2013). This suggests that the length and width, (or 
girth), of the alkyl chain, corresponds to the estrogenic activity of parabens. 
Parabens display agonistic activity towards ERRβ at lower concentration 
than those that activate ERRα, therefore concluding that these chemicals prefer 
ERRβ (Watanabe, 2013). 
Spermatogenesis Effects 
After a single oral administration of 1000 mg/kg of butylparaben to a small 
rat cohort, there was progressive detachment and movement of spermatogenic 
cells into the seminiferous tubules’ lumen, which progressed over time (Alam, 
2014a). Increased apoptosis was confirmed via TUNEL assay, which peaked at 6 
hours after administration, (compared to 3 and 24 hour intervals) (Alam, 2014a). 
In order to understand the mechanism behind this observed effect, Alam et al., 
(2014b), histologically examined the testes of another cohort orally administered 
1000 mg of butylparaben, more closely. These male Sprague-Dawley rats 
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showed a gradual collapse of vimentin filaments, along with decreased levels of 
actin and changes to tubulin expression (Alam, 2014b). Additionally, 
spermatogenic cells dislocated from the basement membrane and sloughed into 
the lumen (Alam, 2014b). To further their understanding, the authors treated 
Sertoli cells in vitro with butylparaben, which displayed increased number and 
size of vacuoles in the cytoplasm and disrupted vimentin filaments, as observed 
with the in vivo study (Alam, 2014b). 
Taking a different approach to these spermatogenesis effects, Zhang et 
al., (2014) gave oral butylparaben at 0, 64, 160, 400 and 1000 mg/kg/day 
concentrations to pregnant Wistar rats, from gestation day (7) and post-natal day 
(21), in order to observe the outcomes on the male offspring. Multiple, significant 
effects were seen in the following male generation including, but not limited to: 
reduced anogenital distance, reduced testes, epididymitis and seminal vesicle 
weight, decreased serum testosterone and increased E2 concentration (Zhang, 
2014). At doses of 400 and 1000 mg/kg/day, there was a significant, dose-
dependent, reduction of epididymal cauda sperm counts and daily sperm 
production in the male offspring (Zhang, 2014). 
Other 
Estrogen sulfotransferase (SULT) acts to down-regulate the levels of 
active estradiol, and are present in the skin to regulate the estrogen receptor 
pathway that controls dermatological effects (Dooley, 2000). Parabens inhibit the 
sulfation of estradiol in the skin and liver, with marginally more influence on liver 
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SULTs (Prusakiewicz, 2007). The potency of SULT inhibition is directly 
proportional to the length of akyl chain of the paraben, thus butylparaben was the 
most effective, of those tested, against skin estradiol sulfation with an IC50 of 37 ± 
5 μM and completely halts sulfation at 1mM concentration (Prusakiewicz, 2007). 
Propylparaben is also large enough to achieve 50% inhibition in skin at 390 ± 
140 μM, however methyl- and ethylparaben only inhibits marginally in 
comparison (Prusakiewicz, 2007). Prusakiewicz et al., (2007) also found that the 
hydrolysis of the parabens did not affect the potency of SULT inhibition and that 
parabens were not effective against the SULT2B1 enzyme which is responsible 
for sulfating hydroxysteriods. These in vitro findings correlated to cultured normal 
human epidermal keratinocyte (NHEK) studies, that showed similar levels of 
inhibition, with the exception of butylparaben, that had a three-fold increase in 
potency in the in vivo model, however could not 100% inhibit regardless of 
concentration (Prusakiewicz, 2007). Though parabens can act as substrates to 
compete against estrogens for the SULT binding site, even the most effective, 
butylparaben, is only 0.032 relatively effective compared to estrone in being 
sulfated (Rozhin, 1974). Therefore, parabens are likely to be affecting estrogen 
sulfation by binding to another portion of the SULT enzyme. 
Breast Cancer 
Concentrations in Tumors 
Utilizing high-pressure liquid chromatography and mass spectrometry, 
Darbre et al., (2004), established a mean concentration of parabens (methyl-, 
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ethyl-, propyl-, butyl- and isobutyl-) via 20 human breast cancer tumors of 20.6 ± 
4.2 ng/g. Methylparaben represented 62% of the total recovered parabens, with 
an average value of 12.8 ± 2.2 ng/g per sample, while benzylparaben was not 
detected in any of them (Darbre, 2004). 
Further expanding upon the research of Darbre et al., (2004), whole 
breast tissue from mastectomized patients for primary tumors, were evaluated for 
methyl-, ethyl-, propyl-, isobutyl-, and butylparaben concentration (Barr, 2012). 
Forty patient samples were isolated into four regional samples relating to the 
axilla, lateral, mid, medial areas of the breast (Barr, 2012). Out of the 160 
samples, one or more parabens were found in 158 (99%), and 96/160 (60%) of 
the samples contained all five experimental parabens (Barr, 2012). Across the 
analyzed samples, the overall median value of total parabens was 85.5 ng/g, 
while the median concentrations for each paraben revealed to be the highest for 
propylparaben with 16.8 ng/g followed closely behind by methylparaben with 16.6 
ng/g, whereas butylparaben, ethylparaben, and isobutylparaben’s median 
concentrations were lower at 5.8 ng/g, 3.4 ng/g, and 2.1 ng/g, respectively (Barr, 
2012). There was considerable variation with regard to the types of parabens, the 
location in one breast, as well as amongst similar locations in different breasts, 
as shown in Table 4, however the median values of each of the parabens in each 
location, was markedly similar (Barr, 2012). A questionnaire for 35 of the 40 
patients revealed that 28/35 (80%) of the patients used underarm cosmetics at 
some point during their lifetime, while 7/35 (20%) reportedly had never used such 
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products (Barr, 2012). When crossing this information with the paraben studies of 
regional breast tissue samples, the 28 users of underarm cosmetics had 
significantly higher levels of propylparaben in the outer (axilla and lateral) versus 
inner (mid and medial) regions, as well as considerably higher levels of 
butylparaben in the outer regions when compared to the inner regions (Barr, 
2012). Fascinatingly, methylparaben concentrations also showed a statistically 
significant decrease when moving from axilla to sternum, however only in the 
reported nonusers of underarm cosmetics (Barr, 2012). 
 Breast Cancer Cell Proliferation 
Propylparaben demonstrates similar disruption of acini formation to that of 
E2, in the breast cancer cell line, MCF-12A (Marchese & Silva, 2012).  After eight 
days of incubation, there was no evidence of lumen clearing via apoptotic cells 
and though present, the basement membrane was significantly larger and non-
spherical compared to controls (Marchese & Silva, 2012). After sixteen days of 
incubation, the cells of the acini were haphazardly arranged, there was 
seemingly no single layer of cells attached to the basement membrane, and the 
lumen was completely filled (Marchese & Silva, 2012). Though this evidence is 
concerning, the relative concentration of propylparaben to that of E2 used by 
Marchese and Silva (2012), was 100-fold greater to elicit similar effects on acini 
formation. 
 
 
 
Table 4 – Paraben concentrations (ng/g) in whole breast samples by region 
 
Tissue samples from radical mastectomies for primary breast tumors; however none of the tumor tissue was used. 
Table from Barr et al., 2012. 
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Table 4 – Paraben concentrations (ng/g) in whole breast samples by region 
 
 
Figure 3 – MCF7 proliferation after incubation with E2 versus parabens. Cells 
from the breast cancer line, MCF7, were incubated with E2, methyl-, ethyl-, 
propyl- and butylparabens for 12 days and the relative concentration of cells for 
each sample are compared here. Figure from Byford et al., 2002. 
 
Parabens induce proliferation of the breast cancer cell line, MCF7, at 
various concentrations for methyl-, ethyl-, propyl-, and butylparaben as shown in 
Figure 3 (Byford, 2002). These effects are inhibited by pure antiestrogen ICI 
182,780, therefore allowing one to assume that this result is mediated by ERRα, 
the known receptor in MCF7 (Byford, 2002). However, parabens required an 
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approximate 5 orders of magnitude higher concentration (10^−5 to 10^−4 M) in 
order to achieve proliferation of MCF7, compared to that of E2 (10^−10 and 
10^−8 M) (Byford, 2002). In addition to MCF7 proliferation by parabens, 
estrogenic activity is also triggered by the presence of parabens (Byford, 2002). 
However, there is a finite range to the paraben concentration between the 
proliferation and initiation of estrogenic activity and cytotoxicity to MCF7 cells. 
Byford et al., (2002) discovered that propyl- and butylparaben maximally affects 
proliferation at around 10-5 M, but caused toxicity at 1-2 x 10-4 M, while ethyl- and 
methylparaben showed weak proliferation of MCF7 cells beginning at a 
concentration of 10 -5 M, with maximum effect around 10-4 M. This maximum 
effect was able to be measured due to the relatively lower toxicity of these 
smaller parabens compared to that of propyl- and butylparaben (Byford, 2002). 
This toxicity likely explains why the degree of gene expression observed with 
parabens is considerably lower than that of E2, as the cells are dying before 
expression can take place.  
Instead of focusing purely on those genes regulated by the estrogen 
receptor, Pugazhendhi et al., (2007) investigated the effects of parabens 
compared to E2 on 19,881 human gene targets. Out of these 19,881 genes, 
2,963 (15%) were altered at least 2-fold by one or more of the treatments: 
methylparaben, butylparaben and E2 (Pugazhendhi, 2007). One thousand nine-
hundred and seventy-two (9%) were altered by at least 2-fold by methylparaben, 
1,292 genes (6%) were altered by at least 2-fold by butylparaben and 857 genes 
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(4%) were altered at least 2-fold by E2 (Pugazhendhi, 2007). All of the examined 
chemicals had a larger influence (2-fold or greater) on the genes via 
downregulation, as oppose to upregulation: 1,256 (62%) versus 716 (38%) by 
methylparaben, 1,014 (78%) versus 287 (22%) by n-butylparaben, and 534 
(62%) versus 323 (38%) by E2, that can be seen in Figure 4 (Pugazhendhi, 
2007).  
 
 
 
 
Figure 4 – Comparative transcription effects of E2 and parabens. Of 19,881 
genes measured, 2,963 had at least a 2-fold difference in transcription levels 
when incubated with E2, methylparaben or butylparaben. Parabens had a much 
higher effect on transcription levels than E2, and tended to down-regulate as 
oppose to up-regulate genes. Figure from Pugazhendhi et al., 2007. 
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Charles and Darbre (2013) determined the no-observed-effect 
concentrations (NOEC), lowest-observed-effect concentrations (LOEC), EC50 
and EC100 values for stimulation of proliferation of MCF7 cells.  When relating 
these concentrations to those that Barr et al., (2012) found in breast tumors they 
found that 43/160 (27%) of the human breast tissue samples contained at least 
one paraben at a concentration ≥ LOEC and 64/160 (40%) > NOEC (Charles & 
Darbre, 2013). Additionally, when all five parabens were combined for MCF7 
incubation, the effects were far greater than any of the individual parabens, as 
shown in Figure 5. 
 
Figure 5 – MCF7 proliferation with varying concentrations of parabens. MCF7 
cells were incubated for 14 or 28 days with EC50, EC75, EC90, and EC100 of 
methyl-, ethyl-, propyl-, butyl-, isobutyl-, or all five parabens, as well as EC50 of 
E2. Though still slower than E2, the combination of all five parabens was able to 
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achieve nearly the same proliferation, far exceeding that which each individual 
paraben could so alone. Figure from Charles & Darbre, 2013.  
The in vitro scratch assay, is a well-established method to measure the 
migration of cells in vitro (Liang, 2007). Khanna et al., (2014) leveraged the 
scratch assay in order to determine whether parabens and 17β-estradiol 
enhanced the migratory potential of MCF7 cells. After incubating the cells in 
either 10–8 M 17β-estradiol, 5 × 10–4 M methylparaben, 10–5 M propylparaben or 
10–5 M butylparaben for 7 days and 20 weeks, the results of the scratch assay 
were compared to control (Khanna, 2014). The long-term incubation of 17β-
estradiol did not increase scratch closure of MCF7 cells compared with control 
(Khanna, 2014). However, long-term exposure to any of the three parabens at 
the concentrations tested, significantly increased the percentage scratch closure 
by the cells when compared to control or to the 17β-estradiol sample. Authors 
performed live cell imaging in order to confirm the results seen by the scratch 
assay, and found the same relative results (Khanna, 2014). Additionally, the live 
cell imagery found that the chemical-deprived sample (control) showed more 
significant movement in the long-term versus the short-term, even when 
compared to the long-term 17β-estradiol sample. Lastly, Khanna et al., (2014) 
leveraged xCELLigence technology (Limame, 2012) to measure the migratory 
and invasive properties of MCF7 cells after the various incubations. Over the 
course of 24 hours, cells with long-term exposure to methylparaben or 
butylparaben showed the greatest level of migration through uncoated 
membranes (Khanna, 2014). The movement of cells through a matrigel-coated 
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membrane was most significantly increased in cells that had long-term exposure 
to methylparaben, thus revealing the invasion potential of this chemical (Khanna, 
2014). Scratch assays and time-lapse microscopy was also used to measure the 
motility response of other oestrogenic-responsive human breast cancer cells, T-
47-D and ZR-75-1, to the same chemical variables exposed over the short and 
long-term (Khanna, 2014). The scratch assay revealed that methyl-, propyl-, and 
butylparaben increased closure time after long-term exposure, while the live cell 
imaging showed an increase in the overall length moved for T-47-D cells, 
however, only methylparaben affected the movement of the ZR-75-1 cell line 
(Khanna, 2014). 
Cytotoxicity 
Handa et al., (2006) used practical concentrations of methylparaben 
(0.003%) and low-dose UVB radiation to assess the effect on HaCaT 
keratinocyte viability, nitric oxide (NO) production, oxidative stress, lipid 
peroxidation and the expression of transcription factors. When the HaCaT 
keratinocytes were exposed to each variable separately, little to no effect on the 
above parameters was seen (Handa, 2006). However, cell death was 
significantly enhanced when 0.003% methylparaben was applied in conjunction 
with the low-dose UVB radiation, inducing reactive oxygen species (ROS) and 
NO production (Handa, 2006). Authors leveraged electro-mobility gel-shift assay 
to relate the above outcomes to the activation of NFκB and AP-1, redox sensitive 
transcription factors which are imperative to cell signal transduction (Handa, 
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2006). They additionally found that alone, 0.0003% or UVB, did not induce lipid 
peroxidation of the cell membrane, however when combined, peroxidation was 
induced in more than just an additive fashion (Handa, 2006). Diving into this 
phenomena further, Kuş et al., (2013) unveiled that methylparaben is converted 
into highly reactive radical and isomeric ketones when exposed to UV (λ > 234 
nm), therefore supporting the findings of Handa et al., (2006).  
Adipocyte differentiation in 3T3-L1 cells, is enhanced by parabens, and 
shows increasing potency with increased alkyl chain length: methyl- < ethyl- < 
propyl- < butylparaben (Hu, 2013). Though competitive assays did not show 
parabens to modulate or bind to the glucocorticoid receptor of preadipocytes, 
parabens did activate the glucocorticoid receptor and/or peroxisome proliferator-
activated receptor γ in the 3T3-L1 cells, as well (Hu, 2013). Lastly, the authors 
showed that parabens, (particularly the larger butyl- and benzylparabens), 
promote the conversion of multipotent stromal cells to adipocytes, and imply that 
their findings suggest that the wide use of parabens may contribute to the obesity 
epidemic (Hu, 2013). 
When incubating NHEKs in 0.001% and 0.003 % methylparaben, after 20 
days the growth rate was no longer the same as control, showing decreased 
proliferation (Ishiwatari, 2007). The low concentration of methylparaben also 
increased the presentation of apoptotic factors, and the cells were flattened and 
enlarged compared to control, which are signs of aging (Ishiwatari, 2007). 
Researchers also found decreased levels of hyaluronan synthases (HAS) 1 and 
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2 with methylparaben application, however there was no change in HAS3 
expression (Ishiwatari, 2007). Additionally, Type IV collagen expression was 
decreased, while HSP27 and involucrin increased expression in the experimental 
group (Ishiwatari, 2007). 
Developmental Effects 
Data from the 2005 - 2006 National Health and Nutrition Examination 
Survey (NHANES) was employed to examine the correlation between endocrine 
disrupting chemicals and allergic sensitization (Savage, 2012). Urinary 
concentrations of parabens, along with specific IgE levels were available for 860 
children between the ages of 6 and 18, and found a statistically significant 
parallel with aeroallergen sensitization for propyl- and butylparabens, however a 
connection with food sensation was not found (Savage, 2012).   
Ali and Elgoly, (2013) administered oral and subcutaneous butylparaben 
to pregnant rats at concentrations of 200 mg/kg bw from gestation day 1 to 
lactation day 21. Offspring performance testing and eventual brain dissection 
showed similar social and learning deficits, as well as physical brain properties 
between the butylparaben rats and the valproic acid autistic-rat model, 
suggesting that butylparaben exposure induces neurodevelopmental disorders 
(Ali & Elgoly, 2013). 
Metabolism/Excretion  
Parabens are metabolized into five different products: 4-hydroxybenzoic 
acid (PHBA) (free acid), p-carboxylphenyl sulfate (sulfuric acid conjugate), p-
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hydroxyhippuric acid (glycine conjugate), p-carboxyphenyl glucuronide (ether-
type glucuronide), and p-hydroxybenzoyl glucuronide (ester-type glucuronide) 
(Tsukamoto & Terada, 1964). When orally administering 0.4 and 0.8 g/kg of each 
methyl-, ethyl-, propyl-, isopropyl-, butyl-, isobutyl-, sec-butylparabens in rabbits, 
the 24 hour urine samples contained free acid (25-39%), glycine conjugate (15-
29%), ether-type glucuronide (10-18%), sulfate (7-12%), and the ester-type 
glucuronide (5-8%) with the listed concentration percentages (Tsukamoto & 
Terada, 1964). 
Harville et al., (2007) analyzed the hydrolysis of parabens in liver versus 
skin, looking at the ability of the differing cellular environments, as well as the 
specific types of microsomes found in each location. Paraben hydrolysis by 
human liver microsomes were ten times faster than human liver cytosol, and 
were 300 to 500 times more active than human skin microsomes, which were 14 
to 67 fold faster than their respective cytosol (Harville, 2007). Researchers were 
also able to pinpoint carboxylesterases as being the main contributors to the 
hydrolysis of parabens and that the rates of metabolism were inversely 
proportional to the ester chain length (Harville, 2007). When contrasting the 
hydrolysis ability of human to rat cellular environments, not only was rat skin 
three to four orders of magnitude more effective, the rat hydrolysis rates were 
proportional to the length of paraben chain; the complete opposite situation to 
that found for human esterases (Harville, 2007). 
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Parabens are relatively stable in human plasma, particularly methyl- and 
ethylparaben, whose concentration remained at 95% after 24 hrs of in vitro 
incubation by Abbas et al., (2010). However, the concentration of propyl-, butyl-, 
and benzylparaben diminished by 50% in the same environment and time frame 
(Abbas, 2010). Considering the number of esterases present in human plasma 
(Li, 2005), Abbas et al., (2010) specifically looked to albumin’s esterase activity 
to account for the metabolism seen in human plasma. However, after incubating 
each paraben in a solution containing a physiological concentration of albumin 
protein (580 mM), there was no hydrolysis up to 6 hours after incubation, and 
after 24 hours, less than 15% had been metabolized (Abbas, 2010). The stability 
of parabens in human plasma was also observed by Ye et al., (2009), where it 
was found that at 4 degrees C, room temperature, and 37 degrees C, there was 
little to no change in the paraben concentration even after 30 days incubating in 
human plasma. 
Though parabens are somewhat stable in human plasma, they are 
promptly hydrolyzed in human liver microsomes, with first-order kinetic rates that 
linearly decrease with the length of the alkyl chain of the paraben, as 
methylparaben is metabolized four times more quickly than butylparaben (Abbas, 
2010). Glucuronidation and hydrolysis of parabens compete in liver microsomes 
for their metabolism via the 1A and 2B families of human UDP-
glucuronosyltransferase (UGT) and a series of esterases as outlined in Figure 6 
(Abbas, 2010). PHBA, produced by the hydrolysis of parabens, is also a 
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substrate for glucuronidation, however UGT has a much higher affinity for 
parabens with a Michaelis Menten constant (Km) about 5 times higher for PHBA, 
comparatively (Abbas, 2010).  
 
Figure 6 – Metabolism of parabens. Parabens are metabolized via hydrolysis by 
esterases and through glucuronidation by UGT. PHBA can also be 
glucuronidated by UGT, however parabens are the preferred substrate. Figure 
taken from Abbas et al., 2010. 
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Dermal Absorption 
If parabens are rapidly metabolized, why are intact compounds found in 
tissues and in excrement? In order to clarify the effects of methylparaben use on 
skin, Ishiwatari et al., (2007) had volunteers apply a lotion-like formula to their 
forearms with a 0.15% concentration of the questionable chemical. They 
subsequently measured the concentration found the stratum corneam after one 
hour to be 18% of the applied quantity, and after 12 hours it had reduced to 
approximately 0.028% of the original concentration in a dose-dependent fashion 
(Ishiwatari, 2007). After applying the same formula twice a day for a month, (a 
typical pattern of use for the type of product), methylparaben accumulated in the 
skin, which is not surprising considering that after 12 hours there was still an 
existing 0.028% concentration present (Ishiwatari, 2007). Utilizing Yucatan 
micropig dorsal skin, authors confirmed that methylparaben also reached the 
epidermis and dermis after 1 hour post-application, with concentrations of 19.3 ± 
1.5 μg/g and 3.2 ± 0.7 μg/g, respectively (Ishiwatari, 2007).  
Highlighting that the parabens that remain in detectable concentration on 
the skin also get absorbed into the blood, Janjua et al., (2007) applied 2 mg/cm2 
cream with 2% of butylparaben onto 26 blinded males, and after a few hours the 
serum concentration peaked with a mean concentration difference of 135 ± 11 
μg/L. Following up to this study, Janjua et al., (2008) had another 26 blinded 
males apply 2 mg/cm2 cream during a control week and then the same cream 
with 2% of butylparaben for another week. During this two-week period, the 
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subjects had 24-hr urine samples collected, which showed a mean increase of 
unconjugated butylparaben excretion of 2.6 ± 0.1 mg over the course of 24 hours 
(Janjua, 2008).  
Pažoureková et al., (2013) followed-up with an in vitro pig-ear model, in 
order to determine the absorption and hydrolysis of methylparaben when applied 
to intact and damaged skin. As expected, the majority of the receptor fluid 
contained PHBA, with 45.8 to 60.9% of the applied dosage for the intact model, 
and 61.0 to 72.6% for the stripped, or “damaged”, model (Pažoureková, 2013). 
Un-metabolized methylparaben did make it to the receptor fluid, however in only 
very small quantities: 2.3 to 3.3% (intact) and 3.2 to 5.5% (stripped), while a 
significant amount of the parent compound remained on the surface (10.7 to 
12.8% and 9.8 to 10.8%, respectively) (Pažoureková, 2013).  
Ishiwatari et al., (2007) additionally found that the samples that contained 
methylparaben with emulsifiers glycerin and squalane, had higher concentrations 
in the stratum corneum, averaging about a 10 pmol/cm2 after one week and 
about 40 pmol/cm2 after four weeks. However, when the absorption of methyl- 
and ethylparaben was examined with various concentrations of the anionic 
surfactant, sodium dodecyl sulphate (SDS), there was a significant reduction in 
the amount of parabens absorbed through the (silicone) membrane, where the 
non-ionic surfactant, Brij 35, did not show a significant difference in the 
concentrations absorbed (Waters, 2013).  
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  Overall/Accumulation 
Many studies estimating the overall exposure level of various 
demographic groups have been performed over the years via analysis of the 
concentration of paraben metabolites in excreted urine. A synopsis of some of 
the more recent findings is in Table 5.  
Strong correlations between the concentrations of methyl- and propyl 
parabens were generally seen (Asimakopoulos, 2014; Wang, 2013; Frederiksen, 
2013). When comparing Danish mother/child pairs from urban versus rural 
environments, Frederiksen et al., (2013), found significantly higher levels of 
parabens in the urine from the urban pairs, while there was a positive correlation 
of a mother’s concentration and her child’s, across both rural and urban 
demographics. Calafat et al., (2010) analyzed the 2005 - 2006 NHANES 
population and drew conclusions for various demographics with regard to higher 
exposure risks of methyl- and propylparaben. The authors found that subjects 
part of the high household income category had significantly higher 
concentrations of tested parabens than the other income classifications, and 
females overall showed higher concentrations than men (Calafat, 2010). 
Additionally, non-Hispanic blacks, and to a lesser extent, Mexican Americans, 
displayed higher methyl- and propylparaben concentrations in their urine when 
compared to their counterparts, concluding that females were 3.2 times more 
likely than males, and non-Hispanic blacks were 5 times more likely than non-
Hispanic whites and 2.5 times more likely than Mexican Americans to have 
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concentrations of methylparaben above the 95th percentile (Calafat, 2010). 
Similar findings were discovered by Smith et al., (2012), where women had 4 
times higher methyl- and propylparaben concentrations than males on average, 
and African Americans had more than 3 times higher concentrations of these 
parabens when compared to Caucasians. The correlations of methyl- and 
propylparaben concentrations between partners were low, as well as there was 
moderate variability between samples from the same subject, with slightly more 
variability among female samples, particularly showing a general decrease in 
concentrations when the woman became pregnant, compared to her previous 
sample (Smith, 2012). 
Some authors utilized the urinary concentrations in order to calculate the 
estimate daily intake values for their demographic. Ma et al., (2013) saw a 
significant difference in the concentrations found in the female versus male 
populations in their study, as well, estimating daily intake of parabens to be 40.8 
and 18.4 μg/kg bw/day for Chinese females and males, respectively. While 
Asimakopoulos et al., (2014) estimated a median intake among Greek males and 
females to be 23.8 μg/kg bw/day. Wang et al., (2013) estimated the Chinese 
daily intake for adult females as 0.88 mg/day, adult males as 0.32 mg/day, girls 
as 0.27 mg/day and boys as 0.17 mg/day.  
 
 
 
 
 
Table 5 - Summary of paraben detection via urinalysis 
a
average of 4 samples per person – mean per individual – percentage of detection based upon all 2,721 samples; 
b
LOD = 0.30 μg/L; 
c
LOD 
= 0.40 μg/L; 
d
LOD = 0.07 μg/L; 
e
LOD = 0.02 μg/L; 
g
LOD = 0.18 μg/L; 
h
LOD = 1.0 μg/L 
Studies of various populations, from different geographic regions are summarized for comparative analysis of the 
total (free and conjugated) median concentration (μg/L) of parabens with the total percentage of detection amongst 
the samples in the parentheses. 
Number of 
Subjects 
Demographic Collected 
Collection 
Year(s) 
Methylparaben Ethylparaben 
Propylparabe
n 
Butylparaben Reference 
100 U.S. males & females Spot 2003-2005 43.9 (99) 1.0 (58) 9.1 (96) 0.5 (69) Ye et al., 2006 
120 Pregnant Spaniards Spot 2004-2008 191.0 (100) 8.8 (87.6) 29.8 (98.3) 2.4 (90.1) Casas et al., 2011 
30 Spanish 4 yo boys Spot 2005-2006 150 (100) 8.1 (80) 21.5 (100) 1.2 (83.3) Casas et al., 2011 
2548 U.S. (NHANES) Spot 2005-2006 63.5 (99.1) <LOD
h
 (42.4) 8.7 (92.7) <LOD
h
 (47) Calafat et al., 2010 
653 
U.S.; 245 males 
408 females 
Spot 2005-2010 82.2
a
 (99.7) - 15.4
a
 (96.5) 0.59
a
 (65.4) Smith et al., 2012 
848 
Danish children  
(4-9 yo) 
Spot 2006-2007 9.37 (95.3) 0.61 (57.9) 0.82 (71.2) <LOD
d
 (49.9) 
Frederiksen et al., 
2014 
129 
Young Danish 
 (5-20 yo) 
24 h 2007 7.70 (95.3) 0.58 (59.7) 1.02 (64.3) ND (14.0) 
Frederiksen et al., 
2014 
111 Pregnant Japanese Spot 2007-2010 75.8 (94) 7.53 (81) 20.2 (89) 0.59 (54) Shirai et al., 2013 
26 Chinese adults Spot 2010 19.5 (100) 0.09 (50) 4.33 (100) <LOD
e
 (35) Wang et al., 2013 
109 
Chinese young adults 
(~20 yo) 
First Morning 
Void 
2010 4.63 (100) 1.40 (100) 3.17 (100) 0.05 (60) Ma et al., 2013 
105 
Pregnant Northern 
Puerto Ricans 
Spot 2010-2012 153 (100) - 36.7 (99.3) 0.4 (58.4) Meeker et al., 2013 
145 Danish Mothers 
First Morning 
Void 
2011 14 (90) 0.89 (66) 1.7 (83) <LOD
d
 (39) 
Frederiksen et al., 
2013 
143 
Danish Children  
(6-11 yo) 
First Morning 
Void 
2011 3.0 (63) 0.40 (50) <LOD
g
 (46) ND (4.2) 
Frederiksen et al., 
2013 
39 
Urban Canadians  
(12-67 yo) 
Spot 2011 25.95 (-) 10.30 (-) 2.80 (-) 0.32 (-) Genuis et al., 2013 
565 
Pregnant Danish 
women 
Spot 2011-2012 11.9 (86.4) <LOD
c 
(49.7) 2.32 (70.1) <LOD
d
 (32.7) 
Frederiksen et al., 
2014 
100 
Greek males and 
females 
Spot 2012 11.6 (100) 2.0 (87) 5.3 (46) 0.9 (46) 
Asimakopoulos et al., 
2014 
40 
U.S. children 
 (3-10 yo) 
Spot 2012 51.8 (100) 0.15 (60) 0.99 (83) <LOD
e
 (15) Wang et al., 2013 
70 
Chinese children  
(9-10 yo) 
Spot 2012 3.66 (100) 0.62 (100) 1.49 (100) 0.03 (99) Wang et al., 2013 
261 
Belgian males and 
females 
Spot 2013 16.1 (100) 1.7 (96.6) 1.2 (83.1) <LOD
b
 (41.8) Dewalque et al., 2014 
3
6
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Going beyond urinalysis for estimated exposure levels, Ye et al., (2012) 
analyzed pooled blood samples from 936 three to eleven year olds that 
participated in the 2001-2002 NHANES for the presence of methyl-, ethyl- and 
propylparaben. Methyl- and propylparaben were detected in all pooled serum 
samples, however ethylparaben was present in fewer than 60%, with total 
(including metabolites) concentrations ranging from 1.6–138 μg/L, 0.2–14.5 μg/L, 
and <0.1–2.0 μg/L, respectively (Ye, 2012). Researchers analyzed different 
demographic information against observed concentrations and found that race 
also played a role in this young group, with methylparaben for 6-11 year olds and 
propylparaben for 3-5 year olds being significantly higher in non-Hispanic blacks 
than for any other ethnic group (Ye, 2012). 
A couple of authors have calculated total paraben exposure based upon 
product concentration levels and estimated intake for the general population. 
Soni et al., (2005) estimated exposure to be 1.26 mg/kg bw/day, with food 
credited for 1 mg/day, personal care products and cosmetics for 50 mg/day and 
pharmaceuticals for 25 mg/day for a 60 kg person. This is starkly contrasted to 
Błędzka et al., (2014) who came up with 12.51 mg/kg bw/day to 28.30 mg/kg 
bw/day based upon the exposure levels outlined in Figure 7. While Soni et al., 
(2005) assumed exposure from cosmetics added around 5 g per day, Błędzka et 
al., (2014) based their calculations on the Cosmetic Ingredient Review Expert 
Panel findings of 2008 that estimated 17.76 g per day for adults via cosmetics 
(CIR, 2008).  
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Figure 7 – Summary of environmental paraben exposure. The vast majority of 
human exposure is due to personal care products, however pharmaceuticals and 
food stuffs also play a significant role in one’s vulnerability to these potentially 
harmful substances. Figure taken from Błędzka et al., 2014. 
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The evidence overwhelmingly points to cosmetics and personal care 
products as being the main culprit for exposure to parabens, and this was 
confirmed in a small sample of 8 individuals that had urine samples taken before, 
during and after the replacement of their typical PCPs, with those that did not 
contain any parabens. For those days with replacement product use, the average 
concentrations of methyl-, ethyl- and propylparaben dropped respectively to 
22.35%, 34.37% and 6.6% of the concentrations from the days of regular product 
use (Koch, 2014). 
Despite the vast exposure of humans to parabens, the question remains 
as to whether or not it accumulates in the organs or tissues. Administering 100 
mg/kg of radiolabeled methyl-, ethyl- and propylparaben to the shaved skin of 
Sprague–Dawley rats, and after 168 hours of collecting samples of excrement, 
only 1.13%/0.94%, 0.57%/0.72%, and 0.89%/1.14% of the remaining respective 
parabens were present in the tissues for males/females (Aubert, 2012). Though, 
35.6%/29.4%, 20.7%/37.4% and 29.0%/23.9% of the remaining respective 
parabens were present in the carcasses of the male/female subjects, the authors 
believe that these high concentrations are due to secondary contamination from 
the presence of the investigated chemicals inside the cages, as the 
administration site was unprotected (Aubert, 2012).  
Alternatives 
Manufacturers of various products will have to continue their use of 
preservatives to protect the public from microbial exposure. However, 
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considering the vast organismal effects of parabens as well as the outstanding 
question regarding accumulation in the body, a review of the alternatives and 
their health effects are in order.  
Phenoxyethanol  
One popular alternative is ethylene glycol monophenyl ether (EGPE), 
otherwise known as phenoxyethanol. However, EGPE even when used in the 
typical 1% concentration as permitted under European regulations, (European 
Commission, 2010), it is not a very effective antimicrobial preservative, 
particularly when it comes to fungus and mold, therefore is typically mixed with 
hydroxybenzoates to provide a wider spectrum of effectiveness (Reynolds, 
1982). One exception though, is that EGPE is frequently used as a preservative 
in vaccines, being found to be equally effective as thiomersal for diphtheria, 
tetanus, and pertussis vaccines (Lowe & Southern, 1994) and more effective 
than thiomersal at 5mg/dose of Prev(e)nar 13™, a pneumococcal vaccine 
(Khandke, 2011).  
In vitro effects of EGPE on human promyelocytic leukemia cells (HL60), 
showed that a 10 minute wash with 0.01% of EGPE displayed moderate 
cytotoxicity after 24 hours of incubation in fresh medium, and 0.1% to 0.5% 
solutions of EGPE displayed a pronounced decrease in cell viability after only 3 
hours in the fresh medium, with cells exhibiting classic signs of apoptosis 
(Anselmi, 2002). After the wash with 1% EGPE, the HL60 cells appeared to 
succumb to sudden death, as there was prominent cytotoxicity at the 0 hour mark 
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(Anselmi, 2002). Oral toxicity studies in rats have determined LD50 ranges 
between 1.26 g/kg and 2.58 g/kg (RIFM, 1983), while dermal exposures to 
rabbits revealed LD50 values spanning 3.10 g/kg (RIFM, 1983), to >5 g/kg (RIFM, 
1982). Reproductive studies with Swiss CD-1 male and female mice that were 
administered varying concentrations via their feed, displayed no changes in the 
ability to produce litters, however there was a small, but significant decrease (10-
15%) in the size of the litters and the weight of the pups in the higher dosed 
groups that was attributed to toxicity of the females in the mating pairs (Heindel, 
1990). Though the fertility of the mice was only slightly compromised, the authors 
observed severe toxicity in the neonates of both sexes produced (Heindel, 1990). 
Pregnant rabbits were dermally-treated with 0, 300, 600 or 1,000 mg/kg bw/day 
of EGPE on days 6 through 18 of gestation, and an examination of the fetuses 
for alterations was performed (Scortichini, 1987). Maternal toxicity was seen at 
the 600 mg/kg/day dose and above, however the fetuses did not show any 
embryotoxic, fetotoxic or teratogenic effects at any dose (Scortichini, 1987).  
Oral exposure of 100, 300, 600 and 1,000 mg/kg/day of EGPE to New 
Zealand white rabbits caused intravascular hemolytic anemia in a dose-related 
fashion (Breslin, 1991). The anemia was illustrated by a decrease in red blood 
count, hemoglobin concentration, and packed cell volume, as well as 
hemoglobinuria, splenic congestion, damage of renal tubules, and an erythroid 
response in the bone marrow for regeneration (Breslin, 1991). When EGPE was 
applied in doses up to 500 mg/kg/day to the skin of male and female rabbits for 6 
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hrs/day, 5 day/week, there were no signs of hemolysis; however there was 
occasional erythema and scaling of the skin at the site of application, though not 
considered to be toxicologically significant (Breslin, 1991). 
Absorption experiments for EGPE with rat and human skin, gave 
permeability coefficients of 17.64 x 10-4 cm/hr and 13.37 x 10-4 cm/hr, 
respectively, for the same flow through system used (Roper, 1997). There was 
some of the applied EGPE remaining in the stratum corneum (4.1%) and dermis 
(4.4%) in the in vitro human skin, 24 hours after application (Roper, 1997). The 
receptor fluid did not contain any phenoxyacetic acid, the known metabolite of 
EGPE, however authors incubated the experimental chemical with rat liver and 
skin cells to measure the enzymatic activity in the two locations (Roper, 1997). 
After 60 minutes, phenoxyacetic acid was found to be generated at 147 nmol/g of 
skin cells, and 2900 nmol/g of liver cells, thus skin can metabolize EGPE at 5% 
the rate of the liver (Roper, 1997). Octeniscept®, comprised of 0.1% octenidine 
dihydrochloride (OCT) and 2% EGPE, was applied to skin samples from cats, 
dogs, cows and horses and allowed to incubate for 28 hours while samples from 
the receptor chamber were taken (Stahl, 2011). There was no detectable amount 
of OCT in the receptor fluid for intact samples, however after 28 hours, 2.64% did 
permeate through the cattle samples that were stripped to replicate damaged 
skin (Stahl, 2011). Contrarily, EGPE was absorbed through all intact skin 
samples, with receptor fluids containing 5.9% (dog) and 28.4% (horse) after 6 
hours, and 35.1% (cat) and 61.1% (horse) after 28 hours (Stahl, 2011). 
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Measuring the amounts of OCT and EGPE that remained in the skin layers after 
the 28 hour experiment also showed very little permeability for OCT, while mean 
concentrations of EGPE was found in the stratum corneum and dermis at 
407.81±67.65 μg/cm2 (cattle), 113.13±44.90 μg/cm2 (dog), 207.21±59.70 μg/cm2 
(cat) and 457.37±144.67 μg/cm2 (horse) (Stahl, 2011). The lipophilic nature of 
EGPE likely plays a significant role in the absorption, however the studied cream, 
Octeniscept®, has also been shown to significantly increase the diameter of 
arterioles in the ears of hairless mice, thus affecting microcirculation (Langer, 
2004). 
When 2,736 patients from St. John’s Hospital and Bristol Royal Infirmary 
of England were patch tested with 1% EGPE in aqueous cream, there was no 
reaction after 2 and 4 days for any patient (Lovell, 1984). Another 130 patients 
were then tested with 1, 5, and 10%, with only 1 patient becoming reactive, 
however he had an existing history of eczema and the authors concluded that 
sensitivity to EGPE was very rare (Lovell, 1984). 
Another common EGPE combination is known by its trademarked name of 
Euxyl K 400. Methyldibromoglutaronitrile (1, 2-dibromo-2, 4-dicyanobutane or 
MDGN) and EGPE in a 1 to 4 ratio, comprises Euxyl K 400, which is equally 
effective against mold, yeast, and bacteria (De Groot, 1996). Concentrations 
added to personal care products for preservative purposes range from 0.05% for 
shampoos and sun protective products, to 0.1% for creams, lotions and raw 
cosmetics (De Groot, 1996). In a retrospective analysis of 1,092 Spanish patients 
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from January 2000 through December 2005, only 15 patients (1.37%) developed 
an allergy to Euxyl K 400, with 11 being positive for MDGN and 2 for EGPE 
(Bordel-Gómez & Miranda-Romero, 2009). Similarly, a survey of 3,177 patients 
in Singapore showed a 2.03% sensitivity reaction to Euxyl K 400, and less than 
1% to EGPE alone (Cheng, 2014). In fact, after MDGN was banned in the use of 
leave-on products in Europe in 2003, in 2007 the European Scientific Committee 
(ESC) established that there was no safe use-level that could be determined and 
that it should not be used in any cosmetic products (ESC, 2007). 
Formaldehyde Releasers  
Free formaldehyde has excellent fungicidal and bactericidal properties, 
however it is a strong skin sensitizer and therefore has been restricted in 
personal care product use (Kireche, 2010). Therefore, substances that slowly 
release formaldehyde, keeping a low concentration at equilibrium , are prevalent 
in manufactured products and are categorized as formaldehyde releasers 
(Kireche, 2010). Common formaldehyde releasers include 1,3-dimethylol-5,5-
dimethylhydantoin (DMDM hydantoin or Glydant), imidazolidinyl urea (Germall), 
diazolidinyl urea (Germall II), quaterium-15 (Dowicil 75, Dowicil 100, Dowicil 
200), 2-bromo-2-nitropropane-1,3 diol (Bronopol), and 5-bromo-5-nitro-1,3-
dioxane, and can be found in baby wipes, vitamins and hair products (Jacob & 
Steele, 2007). 
In a retrospective analysis of Spanish patients that received patch testing 
of formaldehyde or one of the seven releasers studied, the most common 
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sensitizers were formaldehyde with a 1.72% response, imidazolidinyl urea with 
1.05%, quaternium-15 with 0.88% and diazolidinyl urea at 0.79% (Latorre, 2011). 
Of those that were found to be quaterium-15, imidazolidinyl urea and diazolidinyl 
urea sensitive, 50.72%, 29.27% and 19.35% were also reactive to formaldehyde, 
respectively (Latorre, 2011). Researchers also concluded that those sensitized to 
only formaldehyde had a higher frequency of occupational dermatitis than those 
only reactive to formaldehyde releasers, and that the most common site of 
sensitivity was the hands (31.7%) versus the face and legs (31.3% and 24.6%), 
respectively (Latorre, 2011). Warshaw et al., (2015) tested 4,288 patients across 
12 North American sites and found that the positivity rates for all the studied 
formaldehyde releasers had significantly increased since the previously studied 
decade, with quaterium-15 at 6.4%, diazolidinyl urea at 2.1%, and imidazolidinyl 
urea, bronopol and DMDM hydantoin at 1.6% (Warshaw, 2015). Though 
sensitivity rates have increased since approximately 2002, Tudela et al., (2008) 
reports that from 1992 to that point in North America, the rates of positive 
reactions remained stable for DMDM hydantoin and diazolidinyl urea, however 
imidazolidinyl urea did jump from 0.9% in 1975 to over 2% in 2002. Therefore, 
utilization of formaldehyde releasers in formulations has likely jumped 
significantly in the last 10 years. 
Though it would make sense that the cause of the formaldehyde 
releasers’ sensitivity would come from the known sensitizer of formaldehyde, 
however it has been found that not all releasers work in the same fashion. For 
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example, bronopol releases very little formaldehyde, therefore its sensitivity 
reactions have been thought to be caused by the degradation products, including 
2-bromoethanol (Kireche, 2011). However, diazolidinyl urea has shown the same 
genotoxicity as formaldehyde itself via DNA crosslinking, which is believed to be 
due to the quick release of formaldehyde by this agent (Pfuhler, 1996, 2002). 
Therefore the toxicity of each formaldehyde releaser may relate directly to the 
level of formaldhyde that is released. A recent study revealed that diazolidinyl 
urea releases the greatest amount, while DMDM hydantion, quaterium-15, and 
imidazolidinyl urea release similar amounts, and bronopol releases the least 
comparative amount of formaldehyde (Lv, 2015). 
Organic Compounds  
Weak organic acids are used predominantly as a food preservative to 
prevent the growth of fungi that leads to spoilage (Levinskaite, 2012). These 
include sorbic acid and its potassium salt (potassium sorbate), as well as benzoic 
acid and its sodium salt, (sodium benzoate), which are also used in a wide range 
of cosmetic products.  
Generally regarded as safe by the Food and Drug Administration who 
found 156 personal care products that contained sodium benzoate (NaB) in 
1998, the World Health Organization established daily intakes of 5 mg/kg bw as 
acceptable (Nair, 2001). In reviewing multiple rat studies, most observed no 
adverse health effects with ≤1% dosing, while one study showed a significant 
decrease in feed and water intake at 40 mg/kg bw/day, as well as decreased 
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growth (Nair, 2001). Teratogenicity studies in rats, hamsters and rabbits, were 
shown to produce no negative effects at 175, 300, and 250 mg/kg bw/day, 
respectively, and no carcinogenic or mutagenic effects were found (Nair, 2001). 
Rats receiving 200 mg/kg bw/day of NaB for 4 weeks, showed increased 
levels of anxiety and displayed motor impairment (Noorafshan, 2014). Multiple 
studies including 475 American college students (Beezhold, 2014), 1873 3-year 
olds in the United Kingdom (Bateman, 2004), and 153 3-year olds and 144 8/9-
year olds in the United Kingdom (McCann, 2007), found that NaB ingested via 
beverages induced Attention Deficit Hyperactivity Disorder (ADHD) symptoms. 
However, Lok et al., (2013) examined the effects of a capsule containing 45 mg 
NaB versus placebo on 130 Chinese children with a mean age of 8.64 years old, 
and found no significant association with behavioral changes and the 
preservative. 
Neurological anti-inflammatory effects of NaB via the modulation of 
p21(ras) and the mevalonate pathway were discovered in mouse microglia 
(Brahmachari, 2009). Additionally, NaB was found to increase the level of the 
neuroprotective protein, DJ-1 (PARK7), in primary mouse and human astrocytes 
and human neurons (Khasnavis & Pahan, 2012). Jana et al., (2013) found NaB 
to increase the levels of brain-derived neurotrophic factor (BDNF) and 
neurotrophin-3 (NT-3) in the CNS via the PKA – CREB pathway. These positive 
neurological anti-inflammatory effects give NaB the potential to be used in the 
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treatment of human inflammatory disorders, such as Multiple Sclerosis (Pahan, 
2011). 
NaB is able to unfold trypsin by affecting its β-sheet structure and interact 
with it via hydrogen bonds and van der Waals forces (Mu, 2011). Not 
surprisingly, NaB has also been found to affix itself to DNA with hydrogen 
bonding and hydrophobic interactions (Zhang & Ma, 2013). NaB also has been 
observed to stimulate the mitotic process and increase the level of macronuclear 
DNA content, when added to protozoa cultures in addition to sodium nitrate 
(Loutsidou, 2012).  
Leptin, released in proportion to the amount of fat stores, with a crucial 
role in the regulation of appetite, is significantly decreased in a dose-dependent 
fashion in adipocytes treated with NaB, thus could play a role in obesity (Ciardi, 
2012). However, 14 overweight human subjects were treated with 0.1% of NaB, 
(the concentration determined by the FDA to be “generally regarded as safe”), 
and there were not any acute significant changes to the blood serum levels of 
146 measured metabolites (Lennerz, 2015). 
NaB was also found to significantly increase the transcription of the 
phosphate-specific transport system, as well as other efflux systems, in 
Escherichia coli, therefore showing the potential adaptability of bacteria to this 
antimicrobial preservative (Critzer, 2010). Though widely used in food and 
beverage preservation, Périamé et al., (2014) concluded that the maximum 
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allowable concentrations of NaB are inefficient in controlling the adaptability and 
limiting proliferation of bacterium in cosmetic products. 
Potassium benzoate (PB), which is used as an alternative to NaB typically 
for diet foods that must have lower sodium, was analyzed for potential 
teratogenic effects by injecting mice with 280 or 560 mg/kg bw daily for 10 days 
before mating, as well as from gestation day 6 through 15 (Afshar, 2013). 
Fetuses in both dosing groups had eye malformations, including deformed lens, 
retinal folds and undeveloped layers attributed to hemorrhage, therefore the 
authors concluded that PB can induce teratogenic effects, however more specific 
studies are needed (Afshar, 2013). 
Human peripheral lymphocytes were administered 6.25, 12.5, 25, 50 and 
100 μg/ml of NaB and 62.5, 125, 250, 500 and 1000 μg/ml of PB, and while there 
was a significant increase in chromosomal aberrations, sister chromatid 
exchange and micronuclei in almost all treatment groups compared to control, 
only NaB was shown to produce DNA damage via comet assay (Zengin, 2011). 
Potassium sorbate, another commonly used weak organic acid for 
preservation, accelerates the glycation of human serum albumin and well as was 
able to produce advanced glycation end products (AGEs) in the absence of 
glucose (Taghavi, 2013). AGEs are intermediates of the glycation process and 
regulate oxidative stress and the complications of diabetes, therefore potassium 
sorbate could play a role in exacerbating the complications of this disease 
(Taghavi, 2013). Potassium sorbate was applied to a culture of rabbit tracheal 
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ciliated cells and the effects on the ciliary beat frequency was examined (Wang, 
2012). While other preservatives inhibited the frequency of ciliary beating, 
potassium sorbate increased it relative to baseline by 105 ±9.8, 107.6 ± 4.0, and 
117.1 ± 9.5% for 0.24, 0.48 and 0.96% concentrations, respectively (Wang, 
2012).  
Naturally-derived Agents  
Antimicrobial plant essential oils and animal derived antimicrobial agents 
are becoming more popular as a solution for food preservation as the demand for 
natural products increases. The active components found in plant essential oils 
(EO) are isoflavonoids, ketones, acids, phenolic compounds, aliphatic alcohols, 
aldehydes and terpenes (Tiwari, 2009). Generally plant EOs are more effective 
against gram-positive bacteria, than gram-negative, however compounds from 
cinnamon, clove, citral and oregano are successful against both (Tiwari, 2009). 
There are also many antimicrobials agents of animal origin, as animal cells have 
evolved to have host defense mechanisms, which are largely in the form of 
antimicrobial peptides (AMPs) (Tiwari, 2009). As science advances, the 
discovery and isolation of these polypeptides continue, thus the list of agents 
continues to grow. Some of the animal cell derived AMPs include Pleurocidin, 
active against gram-positive and gram-negative bacteria, Defensins, which 
display a wide range of activity across bacteria, fungi and viruses, and 
Lactoferrin, which is effective against both gram-positive and negative bacteria, 
parasites and fungi (Tiwari, 2009). 
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Certain plant EOs have proven to be effective preservatives in personal 
care products, such as Calamintha officinalis Moench (rosemary), that was found 
to meet the European Pharmacopoeia (EP) criteria A (i.e. reduction of the 
bacterial inoculum by a factor of 103 within 7 days of challenge with no increase 
up to the 28th day) at 2.0% concentration in cream formulation, however the 
same concentration in a shampoo formulation could not meet EP criteria A due to 
its insufficiencies against gram-positive bacteria, however in some situations 
satisfaction of criterion B (i.e. reduction by a factor of 103 within 14 days of 
challenge with no increase up to the 28th day) is sufficient to the EP (Nostro, 
2004). Similar effectiveness of the EO of Pimenta pseudocaryophyllus, a native 
Brazilian plant species, was observed to inhibit the growth of Staphylococcus 
epidermidis, Proteus hauseri and other bacteria responsible for causing bad 
perspiration odor, therefore giving it the potential to be used in the formulation of 
personal care products (Suzuki, 2014). Mustard EO is also an effective 
antimicrobial agent, affecting the pH and concentration of intracellular products, 
by damaging the cellular membranes of E. coli and Salmonella typhi (Turgis, 
2009). 
Some aspects of EOs are carcinogenic, as Salvia sclarea and Melaleuka 
quinquenervia can promote estrogen secretion, while others contain 
photosensitizing flavins, cyanin, porpyhrins, and hydrocarbures that cause skin 
erythema or cancer (Bakkali, 2007). Citrus bergamia contains the 
photosensitizing molecule psoralen that forms covalent DNA adducts under 
52 
 
ultraviolet A or solar light and many mint species contain pulegone, which can 
induce cancer via the depletion of glutathione (Bakkali, 2007). Rodents were 
seen to generate carcinogenic metabolites via the safrole compound in 
Sassafras albidum and Octotea pretiosa oils (Bakkali, 2007) Additionally, the 
compunds methyleugenol (from Lauris noblis and Melaleuca leucadenron), D-
Limonene (from Citrus) , and estragole (from Ocimum basilicum and Artemisia 
dracunculus) were carcinogenic for rodents (Bakkali, 2007). However, these 
factors could be balanced by the antimutagenic properties found in many EOs, 
such as mutagen inactivation via direct scavenging, as well as the capturing free 
radicals via antioxidant enzymes (Bakkali, 2007). Promotion of DNA repair and 
inhibition of metabolic conversion by cytochrome P450 of promutagens to 
mutagens, have also been observed (Bakkali, 2007). 
Many EOs have proven to be effective preservatives in food products. 
Vanillin in 2000 ppm effectively delayed the growth of yeast in yogurt, thus 
increasing the shelf-life (Penney, 2004). Oregano and rosemary oil when added 
to minimally processed carrots, inhibited the sensory characteristics of spoilage 
(Ponce, 2010), as did thyme oil (1%) to other minimally processed vegetables 
(Uyttendaele, 2004). Tea catechins when added to red meat at 300 mg/kg, 
increased the shelf life and reduced lipid oxidation (Tang, 2001). Cooked beef 
that has added grape seed extract (1%) also has decreased lipid oxidation and a 
better maintenance of color (Ahn, 2007). As these naturally-derived agents can 
affect the flavor or other sensory aspects of the product, plant EOs are typically 
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used in food products in mixtures in order to reduce the overall concentration 
needed, however determining the right balance of each EO to ensure 
effectiveness at the same time can prove challenging (Tiwari, 2009). 
Methylisothiazolinone 
The heterocyclic organic compound, methylisothiazolinone (MIT), is used 
as a preservative in personal care products, from baby and bath to hair and skin 
care products, with allowed concentrations up to 0.01% (Burnett, 2010). This 
chemical is also used to uphold cleaning agents, to control slime-forming 
microbes in mills, oil field operations, water cooling systems, and to preserve 
paints, adhesives, fuels, coatings, and much more (Burnett, 2010). Though it is 
an effective antimicrobial, Enterobacter gergoviae has shown to adapt and 
proliferate even in the presence of the maximum allowed concentration of 0.01% 
MIT (Périamé, 2014). Mechanisms of adaptation include overexpression of 
detoxifying enzymes and flagellin, as well as the modification of the membrane in 
E. gergoviae (Périamé, 2015).  
In vitro human epidermis models show the absorption of MIT ranging from 
29.5% ± 13.4%, 8.98% ± 3.10%, and 19.6% ± 10.0%  when part of shampoo, 
body lotion and facial cream formulations in a concentration of 100 μg/mL, 
respectively (Rohm & Haas, 2005a). Oral administration of 100 mg/kg bw to CD-
1 mice showed highest concentrations in the liver and the lowest in bone at the 
early time points, but after 48 hours, mean concentrations ranged from 1.1 to 
30.4 ppm in females and 1.2 to 39.4 ppm in males in the bone marrow of 
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subjects (Rohm & Haas, 2003a). The metabolism of MIT was evaluated in 36 
Sprague-Dawley rats, via the collection of urine, feces, and cage rinse at 24-hour 
intervals after the oral administration of 5 or 50 mg/kg bw of the experimental 
substance (Rohm & Haas, 2005b). After 24-hours, most of the chemical was 
recovered (80%-87%) in the urine and cage rinse (53%-70%) and in the feces 
(21%-37%), however after 96-hours, 1.9% to 3.6% remained in the rat tissue, the 
majority of which was in the blood (Rohm & Haas, 2005b). The major urinary 
metabolites were N-methyl-3-hydroxyl-propionamide, 3-mercapturic acid 
conjugate of 3-thiomethyl-N-methyl-propionamide, and N-methyl malonamic acid 
(NMMA) at 4% to 5%, 10% to 23%, and 21% to 23%, of the dose, respectively 
(Rohm & Haas, 2005b). Toxicology studies for various concentrations and 
formulations for MIT are outlined in Table 6. 
In vitro assays with Chinese hamster ovary cells, showed no mutagenicity 
with dosing concentrations of 0.5-40.0 μg/mL of 97.5% of pure MIT, but with 
dosing up to 5000 μg/mL, there were significant aberrations observed (Burnett, 
2010). However, those mutagenic abnormalities coincided with over 40% 
cytotoxicity, thus the possibly of false positive results are high (Burnett, 2010). In 
vivo analysis via various dosing of 51.1% MIT to rats found no mutagenicity of 
hepatocytes at 2 to 4, or 14 to 16 hours after dosing (Rohm & Haas, 2003d). 
Though there are no known carcinogenicity studies with MIT alone, Rohm & 
Haas, et al., (1994) found Kathon CG, (combination of MIT and 
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Methylchloroisothiazolinone [MCIT]), was not a carcinogen in a 2-year water 
drinking study in rats.  
 
Table 6 – Summary of various toxicology studies for MIT 
Concentration Subject Formulation Administration 
Outcome 
Determined 
Reference 
99.7% Rat 
Aqueous 
Solution 
Oral 
LD50 = 235 mg/kg 
(male) and 183 
mg/kg (female) 
Rohm & 
Haas, 
1999a 
97.5% Mice 
Aqueous 
Solution 
Oral LD50 = 167 mg/kg 
Rohm & 
Haas, 
2000a 
9.5-9.9% Rat Body Lotion Oral LD50 > 2000 mg/kg 
Rohm & 
Haas, 
2001a 
9.5-9.9% Rat Shampoo Oral LD50 > 2000 mg/kg 
Rohm & 
Haas, 
2001b 
9.5-9.9% Rat Sunscreen Oral LD50 > 2000 mg/kg 
Rohm & 
Haas, 
2001c 
97.5% Rat 
Aqueous 
Solution 
Dermal LD50 = 242 mg/kg 
Rohm & 
Haas, 
1999b 
9.69% Rat 
Aqueous 
Solution 
Dermal LD50 > 484.5 mg/kg  
Rohm & 
Haas, 
2000b 
51.4% Rat 
Aqueous 
Solution 
Oral 
NOAEL (maternal) 
= 20/mg/kg/d 
Rohm & 
Haas, 
2003b 
51.4% Rabbit 
Aqueous 
Solution 
Oral 
NOAEL (maternal) 
= 10 mg/kg/d 
Rohm & 
Haas, 
2003c 
51.4% Rabbit 
Aqueous 
Solution 
Oral 
NOAEL 
(developmental)= 
30 mg/kg/d  
Rohm & 
Haas, 
2003d 
LD50 = Median lethal dose 
NOAEL = No observed adverse effect level 
 
Differing concentrations, animal subjects and formulations are compared, and 
reveal that the lowest concentrations in non-aqueous solutions have the highest 
tolerance. All concentrations that led to an effect are relatively high, as well. 
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Lethal concentrations (LC50), via 4-hour inhalation rat studies of 53.52% 
and 97.80% MIT, determined 0.35 and 0.11 mg of active ingredient per liter, 
respectively (Burnett, 2010). Forty volunteers had 15 μL of MIT at concentrations 
of 100, 300, and 600 ppm applied to their backs, and after 1 and 24 hour time 
periods displayed 6.3, 1.3 and 6.3 skin irritation indices, respectively, compared 
to control’s 5.0, therefore was found not to be an irritant (Rohm & Haas, 2001d). 
However, since this initial finding, more studies have shown that the prevalence 
of MIT sensitivity is increasing, particularly through contact with industrial 
products that do not have the same concentration limits that cosmetics do 
(Lundov, 2011a).  
A survey of cosmetic products in the Danish market discovered that very 
few are preserved with MIT, and of those that are, they are predominantly rinse-
off products, with 75% of them containing 50 ppm or more, and 25% containing 
95 ppm or more (Lundov, 2011a). Subjects that have displayed contact 
sensitivity to MIT were patch tested with 0.1% (1000 ppm) and 0.03% (300 ppm) 
and displayed 1.4% and 0.6% positive reactivity (Ackermann, 2011). However, 
when comparing rates of sensitivity from 2010 to 2012, Lundov et al., (2013) 
found that it had increased from 1.0% (n = 2802) to 2.0% (n = 2766), in just two 
years. Additionally, in a North American analysis of 4,288 subjects there was a  
5% reactivity rate to MIT, however the formula was in combination with MCIT 
(Warshaw, 2015). Another recent examination has shown that 100% of MIT-
sensitive subjects react to as little as 100 ppm in rinse-off formulas, and 78% 
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reacted to just 50 ppm (Yazar, 2015). This leaves to question whether there even 
is a safe concentration of MIT, even in products that rinse-off. 
Adverse neurological effects have been observed in vitro, where cultured 
neurons exposed briefly to MIT caused toxic reactions including the activation of 
NADPH oxidase, the generation of ROS, and DNA damage, however these 
effects were not seen in glia (Du, 2002). He et al., (2006) outlined the damaging 
MIT effects on immature neurons via the disruption of FAK-SFK complexes, 
concluding that the chemical could have detrimental effects on the developing 
nervous system. In vivo studies that exposed Xenopus laevis tadpoles to less 
than lethal concentrations of MIT, resulted in abnormal neurological function 
without any morphological effects, including an increased vulnerability to seizures 
and visually-mediated avoidance behaviors (Spawn, 2012).  
Comparison 
 
Different preservatives can be found in various types of personal care 
products. An analysis of 67 skin creams in Denmark looked for various 
preservatives, and found the top three preservatives included 1 or more 
parabens in 58 (87%), formaldehyde/formaldehyde releasers in 34 (51%) and 
EGPE in 33 (49%) of the products (Rastogi, 2000). Additionally, though the 
authors found that all the preservatives were within the limits of the maximum 
allowable concentration, 45% of the skin creams were incorrectly labeled with 
regard to preservative content (Rastogi, 2000). A Polish investigation of 66 
cosmetic products, 5 cleaning agents and 17 pharmaceutical products found 
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methylparaben and NaB were the most commonly used preservatives in 
cosmetics, while pharmaceuticals rarely contained methylparaben, and cleaning 
agents contained MIT, MCIT, NaB and methylparaben (Baranowska, 2014). The 
survey of 4,680 German products by Uter et al., (2014) found that NaB (8.8%), 
potassium sorbate (7.9%), EGPE (4.4%), as well as parabens and formaldehyde 
releasers were contained in deodorants. Additionally, products marketed for 
external intimate hygiene (n = 27) included NaB (48.1%), MCIT/MIT (44.4%), 
EGPE (44.4%), potassium sorbate (22.2%), diazolidinyl urea (11.1%), 
imidazolidinyl urea (7.4%), ethylparaben (3.7%) and MIT (3.7%) (Uter, 2014).  
Comparing the effectiveness of potassium sorbate, NaB and 
methylparaben for the preservation of dry sausages, Matos et al., (2007) 
determined methylparaben to be more effective than the other preservatives 
against almost all fungi. Potassium sorbate was found to be more effective at 
inhibiting the growth of mold than NaB, however authors concluded that 
methylparaben was the most overall effective preservative to inhibit spoilage and 
the growth of toxigenic molds in dry sausage (Matos, 2007). The comparative 
effectiveness of plant extracts at 2.5% (Matricaria chamomilla, Aloe vera, 
Calendula officinalis), essential oils at 2.5% (Lavendulla officinalis, Melaleuca 
alternifolia, Cinnamomum zeylanicum) and methylparaben at 0.4% 
concentrations in cosmetic emulsions applied to the skin of volunteers had 
samples taken at 0, 2, 4, 6 and 8 weeks to evaluate the growth of bacteria, yeast 
and mold (Herman, 2014). Of all the samples, cinnamon oil was the only 
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preservative that completely inhibited the growth of bacteria, yeast and mold, and 
could be used as a replacement to methylparaben in the preservation of 
cosmetic products (Herman, 2014). 
The percent occurrence of dermatitis across many of the previously 
described preservatives is outlined in Table 7. In one study, the authors noted 
that 9.4% of the positive patch tests did not become positive until day 7 (Cheng, 
2014). Dinkloh et al., (2014) determined MIT to be the leading cause of 
sensitization by far, while EGPE and parabens rarely lead to dermatitis. A subset 
of 113 subjects that have poor tolerance to cosmetics displayed allergies to Euxyl 
K 400 at 18.6%, Kathon CG at 7.1%, bronopol at 5.3%, DMDM hydantoin at 
2.6%, and quaternium-15 at 0.9% (Kieć-Swierczyńska, 2006). There have been 
significant changes in the measured reactivity of individuals to preservatives. 
Warshaw et al., (2015) compared the patch testing results of North American 
patients in 2011 - 2012 to those from 2009 - 2010 and 2000 - 2010, and found 
statistically significant increases in sensitivity to MCIT/MIT and parabens, while 
sensitivity to formaldehyde releasers significantly decreased. However, a more 
longitudinal approach went as far back as 1985 for a variety of preservatives and 
is outlined in Figure 8 (Thyssen, 2010). 
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Figure 8 – Rates of sensitivity to preservatives from 1985 to 2008. Overall 
sensitivity to at least one preservative increased significantly over the course of 
time. Many of the lesser sensitizing chemicals have remained relatively constant 
in the rates, MDGN and formaldehyde has been quite volatile. Figure taken from 
Thyssen et al., 2010. 
 
Comparing the rate of reactivity to the different types of personal care 
products, Travassos et al., (2011) found skin care products (34%), hair care 
products (20%), body cleansing products (14%), sun care products (10%), facial 
cleansers and deodorants (6%) and lastly intimate hygiene products (3%) to be 
responsible in decreasing order. Subsequently analyzing the presence of various 
preservatives in these types of personal care products, the results are defined in 
Figure 9. 
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Figure 9 – Composition of PCPs based on sensitizers. Formaldehyde and 
MCIT/MIT span the greatest number of product types, while imidzaolidinyl urea 
and bronopol are focused in just one or two formulations. Interestingly the least 
amount of diversity in sensitizing preservatives is found in the intimate hygiene 
products. Figure taken from Travassos et al., 2011. 
 
Using preservatives in combination has been shown to allow smaller 
concentrations of each individual chemical and still have the same efficacy. For 
example, if one also adds EGPE, the levels of allergenic preservatives, 
MCIT/MIT, MIT, and diazolidinyl urea could be reduced 8 to 16 fold compared to 
when they are used alone (Lundov, 2011b). The addition of Lemon Grass oil also 
increases the spectrum of activity for EGPE (Onawunmi, 1988). The inhibition 
efficacy of EOs alone (0.5%) and in mixtures (1.0%), as well as in combination 
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wtih synthetic preservatives (DMDM hydantoin and 3-iodo-2-propynyl butyl 
carbamate) revealed a synergistic effect allowing the reduction of synthetic 
preservatives up to 8.5 times (Kunicka-Styczyńska, 2009). For example, tea tree 
oil alone at 0.5% was not effective in preserving a soft body balm, however when 
5% of a solubilizer and 0.3% of a synthetic preservative (DMDM hydantoin [0.1%] 
and 3-iodo-2-propynyl butyl carbamate [0.3%] combination) the preservation of 
the cosmetic product was successful (Kunicka-Styczyńska, 2011). Additional 
synergy was also observed when eucalyptus and mint EOs were combined with 
methylparaben against Pseudomonas aeruginosa, as well as mint, oregano, and 
sage EOs with propylparaben and imidazolidinyl urea against Staphylococcus 
aureus (Patrone, 2010). Though the use of preservatives in combination allows 
for lower concentrations of each chemical, this would put more varietals of 
preservatives into the environment. The increased use of various preservatives in 
combination could cause additional issues for the activated sludge process in 
sewage treatment plants. Already multiple preservatives were discovered in 
treatment plants, including bronopol, diazolidinyl urea, propylparaben and 
MCIT/MIT, and the presence could affect the functionality of sewage treatment 
(Carbajo, 2014). 
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Table 7 – Occurrence of dermatitis for various preservatives. 
Number of 
Subjects 
3,177 69,487 1,937 1,927 ≤18,179 
Parabens 2.58% 1.1% 0.3% 1.1% 0.5% 
EGPE <1% - - - - 
MDGN 1.2% 3.2% - - 
3.7% 
(n=7511) 
MDGN/EGPE 
(Euxyl K 400) 
2.03% - 3.7% 1.7% - 
MCIT/MIT 
(Kathon CG) 
1.75% 3.2% - 1.4% 1.8% 
Quaternium-
15 
1.43% - 0.8% 0.7% 1.0% 
Diazolidinyl 
urea 
1.37% - - 0.9% 
1.6% 
(n=11270) 
Imidazolidinyl 
urea 
<1% - - 0.7% 
0.8% 
(n=11271) 
Bronopol <1% 1.3% - 1.9% 
0.6% 
(n=11272) 
DMDM 
hydantoin 
0% - - - 
0.7% 
(n=1946) 
Reference Cheng, 2014 Dinkloh, 2014 
Kieć-
Swierczyńska, 
2006 
Dastychová, 
2008 
Thyssen, 
2010 
 
Comparing across studies, the relative reactivity of Euxyl K 400 versus just 
EGPE, further justifies the assumption that the sensitivity is from the MDGN in 
the combination and not from EGPE. MCIT/MIT also shows a relatively greater 
rate of sensitivity, while parabens and the formaldehye releasers are somewhat 
docile. 
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DISCUSSION 
 
Significant levels of exposure to parabens occur via personal care 
products, with estimates ranging from 31.0 to 766 μg/kg bw/day based upon 
product concentrations with hand and body lotions being the main contributors 
(Guo, 2013). Parabens are typically used in combination, therefore increasing the 
levels of exposure. 
Pregnant mothers’ urinalysis has shown almost 100% presence of at least 
one paraben, as well as statistically significant correlations with their newborn’s 
urine (Kang, 2013). Additionally, correlations between mother’s urine 
concentrations and amniotic fluid levels, (Philippat, 2013), as well as mother 
versus cord blood samples, (Towers, 2014), validate fetal exposure. Infant 
exposure to parabens does not cease after leaving the womb, as breast milk 
samples can contain at least one paraben 15 to 80 percent of the time, with 
propylparaben being a significant contributor (Schlumpf, 2010 and Rodriguez-
Gómez, 2014).  
Various paper products including flyers, business cards, food cartons, etc., 
also lead to added exposure to parabens, however researchers included sanitary 
wipes in their estimation of exposure, which one can argue is more of a personal 
care product. Therefore, the inclusion of sanitary wipes could skew the mean and 
range of concentrations; however one would likely be confident with the median 
estimate of 55.1 ng/g (Liao, 2014). Indoor air samples from various countries 
confirm another area of exposure, with again methyl- and propylparaben being 
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the main culprits, however depending upon location, this exposure could or could 
not be significant (Canosa, 2007).  
Methylparaben is also a large contributor to paraben concentrations in 
wastewater and sewage sludge, present in almost 100% of samples in France, 
U.S., Japan and Korea. Parabens, again mostly methyl-, are also in ground water 
and reservoir samples (Gasperi, 2014 and Liao, 2013a). Though there was no 
variance in concentrations in the ground water, the time of year and distance 
from landfills, did make a difference in the concentrations in reservoirs (Peng, 
2014). This could be due to physical nature of how the water is held, as the soil 
acts like a natural filter. Additionally, being a larger body of water, the majority of 
run-off will head to a reservoir, therefore the proximity to landfills and the time of 
year makes sense in creating variables in these concentrations, as it likely does 
for other chemicals.  
Though significant concentrations of multiple parabens have been found in 
soil and groundwater, even when 7.14 ng of methylparaben resides in the soil 
where vegetables grow, there are no detectable levels in the grown vegetables 
(Sabourin, 2014). However, when examining various food products, (including 
fruits and vegetables), bought at various stores around China, 99% of the 
samples contained at least one paraben with a mean of 39.3 ng/g (Liao, 2013b). 
A similar survey of food products in Albany, NY, U.S. discovered at least one 
paraben in 90% of the samples, and a mean of 9.67 ng/g (Liao, 2013c). 
However, food samples from the United Kingdom found much lower incidence 
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and mean concentrations (Fussell, 2014). Therefore, paraben exposure from 
food cannot be ignored, but is location dependent. 
All examined parabens, (alkyl chain = 1-10), show stable interaction 
energy and bond to the human estrogen receptor, with more energy releasing as 
the alkyl chain length increases (Byford, 2002). Additionally, methyl- through 
butylparaben can pair-up to bind with the receptor and release even more energy 
(Byford, 2002). Not only can parabens bind to the estrogen receptor, they also 
activate ERRα and ERRβ with increasing alkyl chain length, as well, though there 
may be some preference to ERRβ (Gomez, 2005). The most potent, 
butylparaben, was still 105-fold less potent than the most potent estrogen, 17β-
estradiol (E2) (Gomez, 2005). However, the authors may not have saturated the 
samples in order to allow for the parabens to pair-up in the binding site, which 
could have increased the activity. Parabens can not only directly bind to estrogen 
receptors to induce their hormonal effects, but also affect SULTs’ ability to down-
regulate the amount of naturally occurring estrogens, further potentiating the 
down-stream effects of the estrogen receptor (Dooley, 2000). Additionally, even if 
the measured activity of parabens is significantly lower than that of E2, 
consideration must be taken that these chemicals are not in an isolated 
environment. Estrogen disruptors have been shown to work in tandem and 
induce effects greater than the sum of the individual elements in the setting 
(Orton, 2014). 
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Butylparaben significantly affects the testes’ ability to produce viable 
sperm, however the rats that displayed these adverse effects were mega-dosed 
with very high concentrations (Alam, 2014a). Though the connection cannot be 
denied, the likelihood that a one would be exposed to 1000mg/kg bw/day is very 
rare. However, the dose-dependent effects of 400 mg/kg bw/day and above in 
the offspring of treated rats, is disturbing, especially when taking into the 
consideration that there is proven prenatal exposure in humans (Zhang, 2014). 
In 2004, the isolation of intact parabens from breast cancer tumors 
created much interest (Darbre, 2004). Authors established an overall mean 
concentration of 12.8 ± 2.2 ng/g, and with methylparaben being 62% of that 
which was recovered (Darbre, 2004). More recently, whole tissue divided into 4 
regions of the breast from mastectomized patients for primary tumors, found 
parabens present in 99% of the samples, and 60% of them contained all 5 
compounds, establishing a median value of 85.5 ng/g (Barr, 2012). Similarly, 
methyl- and propylparaben were present in higher amounts, not surprisingly 
given their vast co-occurrence in personal care products. Assuming the mean of 
the past analysis is comparable to the median of the more recent study, the 
increased concentration could be attributed to higher exposure levels over time, 
or the technology has advanced to better isolate parabens from the samples.  
Methyl- through butylparaben induces the proliferation of breast cancer 
cells, but at concentrations significantly higher than that which is needed for E2 
to produce the same effect (Marchese & Silva, 2012). Another complicating 
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factor, is that parabens have a finite concentration range between cellular 
proliferation with estrogenic activity and cytotoxicity of the cancer cells, therefore 
making the measuring of such effects for these chemicals comparatively difficult 
(Byford, 2002). Additionally, parabens were found to increase the migration of 
MCF7 cells significantly more so than E2 at the same relative concentrations that 
produced the previously described estrogenic activity, and to a greater scale 
when the cells were exposed over a longer period of time (Khanna, 2014). Also, 
when establishing an NOEC and relating this to the concentrations found in 
breast cancer tumor samples, 40% of the samples contained concentrations 
above this NOEC (Charles & Darbre, 2013). Looking at the effects of parabens 
on breast cancer cells, as whole, paints a clearer picture than just that of the 
relative concentration to E2 to produce estrogenic activity. 
Beyond just the estrogen receptor regulated genes, methylparaben alters 
at least 1,972 human gene targets by at least a 2-fold change in transcription, 
while E2 only affects 857 genes (Pugazhendhi, 2007). The majority of the 
alterations by both, resulted in the downregulation of the manipulated genes, 
mostly within the metabolism and developmental sectors (Pugazhendhi, 2007). 
Therefore, parabens’ genotoxicity may reach beyond the effects on the estrogen 
receptor. 
When exposed to ultraviolet B radiation, as little as 0.0003% of 
methylparaben is converted into highly reactive radical and isomeric ketones 
which induces lipid peroxidation and keratinocyte death, at rates greater than that 
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of ultraviolet B alone and that which would be additive to it (Handa, 2006 and 
Kuş, 2013). Given the fact that the majority of topically applied personal care 
products, approximately 60% of which are leave-on (Guo, 2013), contain 
parabens and are likely to be exposed to solar UVB radiation, one would 
presume a greater risk for skin cancers. Additionally, methylparaben 
concentrations as low as 0.001% decreased the proliferation of incubated 
keratinocytes, and instigated the signs of aging, with the cells presenting 
flattened and enlarged when compared to control, as well as showing an 
increase in apoptotic factors (Ishiwatari, 2007).  
Paraben exposure in 6 to 18 year olds is statistically correlated to allergen 
sensitization to airborne substances, however not to food stuffs (Savage, 2012). 
Rat studies suggest additional developmental adverse effects of paraben 
exposure, as gestational exposure led to social and learning deficits, as well as 
physical brain properties that were similar to autism (Ali & Elgoly, 2013). Again, 
given that fetal and infant exposure has been shown in humans, parabens could 
play a role in the development of allergies and/or autism. 
Many studies of the metabolism of parabens are performed in rats, 
however the hydrolysis of parabens in rat models are 3 to 4 times more effective, 
and the effectiveness is proportional to the akyl chain length, while human 
models show methylparaben is metabolized four times more quickly than 
butylparaben (Harville, 2007). Additionally, in vitro models with human skin and 
liver microsomes, found the liver 300 to 500 times more effective in the 
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hydrolysis of parabens (Harville, 2007). Though there are a number of esterases 
in the human plasma, methyl- and ethylparaben remained at 95% of their 
administered concentration after 24 hours, while other parabens decreased by 
50% under the same conditions (Abbas, 2010). This could lead to increased 
durations of circulating parabens that could deposit elsewhere in the body, before 
being metabolized by the liver.  
Studies with human volunteers have shown that with a typical twice a day 
application of methylparaben at only 0.15%, accumulations of the product occur 
within the skin (Ishiwatari, 2007). Considering that up to 0.4% of a single and 
0.8% of a combination is allowed in the United States, one would expect the 
accumulation to be higher in a typical formulation applied to the skin. Topically 
applied formulas that contain parabens, also increase the urinary excretion levels 
(Janjua, 2008), therefore not all of the absorbed parabens are being metabolized 
either at the level of the skin, or at the liver. Some surfactants, such as glycerin 
and squalane, may play a role in enhancing the absorption of parabens, as 
studies show higher levels of methylparabn in the stratum corneum when 
compared to formulations that did not contain these surfactants (Ishiwatari, 
2007). Though, the type of surfactant likely plays a significant role, as anionic 
surfactants seem to reduce the absorption of parabens (Waters, 2015). However, 
this latter study was performed with a silicone membrane, thus translating the 
result to a real life scenario may be difficult. 
71 
 
When looking at the overall levels of urinary excretion against each other, 
one immediately notices the variability based upon geographic region. Exposure 
levels, based upon more recently collected samples, seem to be much higher in 
North American countries when compared to Asian or European. Additionally, the 
timing of sample collection creates another variable, as more recent figures from 
European countries show much lower concentrations when compared to those 
samples collected prior to the 2012 decision by the Scientific Committee on 
Consumer Safety of the European Union.  
Correlations between methyl- and propylparaben exposure are consistent 
with the co-occurrence of these parabens in measured products (Asimakopoulos, 
2014; Wang, 2013; Frederiksen, 2013). Mother and child pairs are also 
correlated, as they are likely using the same or similar personal care products 
(Frederiksen, 2013). Various demographics seem to put individuals at higher 
exposure levels, such as: being female, living in an urban environment, having a 
higher household income, being a non-Hispanic black, and to a lesser extent, 
being Mexican American (Calafat, 2010 and Smith, 2012). All of these 
demographic variables likely relate to higher personal care product use, with the 
exception of living in an urban environment. These urban-living individuals likely 
have a higher level of exposure than their suburban counterparts, due to the 
other areas of paraben exposure, for example from air, paper, and food products.  
Daily estimated intakes based upon urinary output vary significantly 
amongst authors. In 2014, the estimate for Greek males and females was 
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calculated as 23.8 μg/kw bw/day (Asimakopoulos, 2014). A 2013 estimate for 
Chinese males and females was 18.4 and 40.8 μg/kw bw/day, respectively, 
which gives the mean of 29.6 μg/kw bw/day (Ma, 2013), thus is comparable to 
the Greek calculation. However, another 2013 estimate for the Chinese 
population, came up with 0.32 mg/day for males and 0.88 mg/day for females 
(Wang, 2013). If we assume the weights of 60 kg for a male and 50 kg for a 
female, the estimate becomes 0.53 and 1.76 μg/kw bw/day for males and 
females, respectively, which is significantly less than the other Chinese estimate.  
The difference could be explained by the fact that the former author, Ma et al., 
(2013), collected urine samples from almost every geographic region of China, 
while the other, Wang et al., (2013), collected all samples from only Shanghai. 
Additionally, Wang et al. had only 26 samples from predominantly young adults 
for which to determine a median, which could have also skewed the calculation. 
Calculations of exposure based upon estimate environmental exposure, 
point to much higher numbers. Soni et al., in 2005, estimated 1.26 mg/kg bw/day, 
while a more recent calculation (Błędzka, 2014) that took more than just food, 
cosmetics and pharmaceutical exposures into account, pointed to 12.51 to 28.30 
mg/kg bw/day. Though the later calculation took more elements of exposure into 
account, they also took the Cosmetic Ingredient Review Expert Panel findings of 
2008, which pointed to an estimated 17.76 g/day of exposure via cosmetics, as 
opposed to Soni et al.’s use of 5 g/day. 
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The main question outstanding is whether or not these lipophilic parabens 
accumulate in human tissues after exposure. An attempt to answer this question 
using a rat model, pointed to about 0.9% accumulation in rat tissues (Aubert, 
2012). However, the authors only administered parabens to the subjects for a 
course of 7 days. Granted these are rats and not humans, however each day for 
a Sprague-Dawley rat is approximately equivalent to 34.8 human days 
(Sengupta, 2013), therefore the course of the study could equate to 66.7% of one 
human year. When one thinks about the adverse effects of paraben exposure, 
particularly for a cancer outcome, the time frame would likely be multiple years or 
even decades. Additionally, it has already been outlined that parabens are likely 
metabolized differently and more efficiently in rats than in humans, which makes 
this study even harder to correlate to humans. 
A popular alternative for personal care product preservation is 
phenoxyethanol (EGPE), however alone it does not effectively handle the growth 
of fungus and mold, therefore is typically mixed with other preservatives for 
complete effectiveness (Reynolds, 1982). In vitro human skin absorption studies 
found 4.1% and 4.4% respectively in the stratum corneum and dermis, remaining 
after dosing, and no phenoxyacetic acid, the known metabolite, in the receptor 
fluid (Roper, 1997). Therefore, there is probably very little metabolism of EGPE 
at the level of the skin, which was confirmed by further investigation finding that 
EGPE is metabolized in the skin at only 5% the rate of the liver (Roper, 1997). 
Being used in product formulations for over 20 years the fair amount of evidence 
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suggests that it is predominantly safe. Particularly in topical applications, as 
studies that administered 500 mg/kg bw/day to rabbits produced no adverse 
effects other than some occasional erythema and scaling of the skin (Breslin, 
1991). Given the large dose administered, this is likely to be expected. Though 
the potential for significant absorption of EGPE is concerning, multiple toxicology 
studies have shown no adverse effects at concentrations much higher than that 
which would be found in a PCP. 
Patch testing of 1% of EGPE alone resulted in none of the subjects 
developing a reaction after 4 days (Lovell, 1984). However, other authors show 
that patch testing should continue for at least 7 days, as some chemicals do not 
cause a reaction until that point (Cheng, 2014). Therefore, it is a possibility that 
Lovell et al.’s dermatitis results for EGPE are underestimating the reactivity rates, 
due to an insufficient period of time of patching. As EGPE is generally in 
combination for formulation, attention should be paid to its counterpart. For 
example, Euxyl K 400 has shown to cause sensitivity in 2.03% of a large 
population, but the majority of the sensitivity was from the other active ingredient, 
MDGN, which is now banned in Europe (Cheng, 2014). 
Leveraging the antimicrobial power of formaldehyde without the strong 
sensitization, formaldehyde releasers are common preservatives found in 
personal care products. Some of them can be quite sensitizing, particularly 
quaterium-15, diazolidinyl urea, and imidazolidinyl urea (Latorre, 2011), all of 
which have been shown to have increased levels of sensitivity over the past 10 
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years (Warshaw, 2015). This is testament to a likely increase of use in 
formulation manufacturing. Diazolidinyl urea comparatively releases some of the 
most formaldehyde, and has been shown to match its released chemical in 
outcomes of genotoxicity studies (Lv, 2015). While bronopol releases very little 
formaldehyde, it is typically a less sensitizing agent (Kireche, 2011). Therefore, 
given the variations of these compounds in their levels of formaldehyde release, 
it is likely that these varying degrees directly relate to the amount of toxicity and 
sensitivity for this category of preservatives. 
Another popular category of preservative, which is predominately used in 
food products, though also present in personal care items, is weak organic acids. 
These products, including sodium benzoate and potassium sorbate, are 
generally regarded as safe, when analyzing the physical ramifications of 
exposure (Nair, 2001). However, studies in both rats and children have shown 
correlations between sodium benzoate intake and higher levels of anxiety and 
symptoms of ADHD (Noorafshan, 2014, Beezhold, 2014, Bateman, 2004 and 
McCann, 2007). On a potentially positive note, sodium benzoate has also shown 
neurological anti-inflammatory effects that could possibly be used for the 
treatment of diseases (Pahan, 2011). At the same time, sodium benzoate 
interacts with proteins, causing them to unfold, as well as can affix itself to DNA 
and stimulate mitotic processes (Mu, 2011 and Loutsidou, 2012). Considering 
that NaB can cross the blood-brain barrier, there should be significant bio-
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engineering behind any potential medication generation so that none of the 
harmful genotoxicity can play a role. 
Other concerns regarding weak organic acid use in human utilized 
products, include potassium sorbate’s ability to produce advanced glycation end 
products (Taghavi, 2013), and NaB’s stimulation of Leptin release from 
adipocytes (Ciardi, 2012). These findings have large implications for the current 
obesity epidemic. However, given that a standard dosing of NaB did not produce 
any acute changes to obese subject’s serum metabolites (Lennerz, 2015), further 
studies looking to the long-term effects of NaB intake, should be performed to 
ensure that these preservatives are not potentiating this rampant issue. 
Naturally occurring antimicrobial solutions derived from plants and 
animals, have been proven to be effective in many food products, but also in 
personal care items (Tiwari, 2009). Plant essential oils (EOs), such as that from 
cinnamon, clove, citral and oregano, are effective against the spectrum of 
bacteria (Tiwari, 2009), and rosemary EO meets the EP criteria A at 2.0% in a 
cream formulation (Nostro, 2004). Though, it was only effective in meeting 
criteria B in a shampoo (Nostro, 2004), if in combination with another EO it would 
likely have effectively met criteria A for the shampoo formulation, as well. EOs 
are also valuable in the preservation of food products, but given the typically 
strong flavor/odor associated with them, it can be challenging to strike a balance 
between product flavor and preservation. 
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Some EOs have been shown to produce carcinogenic byproducts and 
some have induced cancer in rodent studies (Bakkali, 2007). Therefore, not all 
plant-derived EOs may be suitable for the preservation of human consumed or 
applied products. However, at low doses, these carcinogenic effects may be 
balanced by the antimutegenic properties of many EOs, such as mutagen 
scavenging and free radical inoculation via antioxidant enzymes (Bakkali, 2007). 
When assessing EOs for manufacturing purposes, investigation into the 
generation of these carcinogenic metabolites should be performed, specifically at 
the concentrations of intended use. 
A very effective antimicrobial, Methylisothiazolinone (MIT), is used for a 
wide range of product types, however is only allowed in personal care products in 
concentrations up to 0.01% (Burnett, 2010). Given the rates of contact sensitivity 
that MIT induces, and that these rates have doubled in just two years (Lundov, 
2013), it is not surprising that the majority of PCPs that contain MIT are in very 
low doses and are predominantly in those that rinse-off (Lundov, 2011a). The 
very recent increase in sensitivity is likely due to the expansive product list in 
which MIT is used, as well as the high proportion of baby products that rely in its 
antimicrobial power, therefore increasing the levels of exposure across 
populations and starting these exposures at an extremely young age (Burnett, 
2010).  
MIT causes neurological damage in vitro and in vivo (Du, 2002 and He, 
2006), which is concerning giving the significant level of absorption seen in 
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shampoo, body lotion and facial cream formulations (Rohm & Haas, 2005a). The 
measured LD50 concentrations for oral and dermal exposure in rats are very high 
(Rohm & Haas, 1999-2003), which should alleviate the majority of the concern, 
however these rat toxicology studies should be accepted cautiously, as the not 
only are they over 10 years old, they were also performed by the manufacturers 
that brought MIT to the market for human product preservation. 
Different countries have assorted trends of use for the diverse 
preservatives that have been discussed thus far. This is likely due to the variable 
regulations and relative public awareness within these geographic regions, thus 
molding the manufacturing tendencies. Different agents can be more effective 
depending upon what exactly is being preserved. However, considering that 
paraben exposure is predominantly from personal care products, this is the area 
where the attention should be focused. Therefore, the fact that a head-to-head 
efficacy trial for preserving cosmetic emulsions applied to the skin, resulted in the 
EO of cinnamon being more effective than other EOs and even methylparaben at 
its maximum allowed concentration of 0.4%, is promising (Herman, 2014). 
Across all reviewed studies, MDGN (or combinations in which it is 
contained, such as Euxyl K 400) shows the highest rates of sensitivity 
comparatively to other preservative agents, which likely why Europe banned its 
use in personal care products in 2008 (Cheng, 2014, Dastychová, 2008, Kieć-
Swierczyńska, 2006 and Thyssen, 2010). Kathon CG (MCIT/MIT) is also a 
relatively high sensitizer and over the last ten years rates have significantly 
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increased, while those of formaldehyde releasers have mostly decreased in the 
same time frame (Warshaw, 2015). Interestingly, parabens have been on the 
market for decades, however the rates of sensitivity have been fairly stable for 
the last 25 years (Thyssen, 2010).  
Using preservatives in combination allows manufacturers to use lower 
concentrations of each chemical to reduce potential reactivity, however while still 
maintaining the integrity of the product. However, the use of preservatives in 
combination should be used with caution, as this would increase the number of 
ingredients individuals are exposed to overall, therefore potentially increasing 
levels of sensitivity. Additionally, there are many environmental factors that must 
be taken into consideration, as these chemicals are sloughed or washed off of 
user’s bodies and end up in the air, but mostly in sewage and water run-off. 
Sewage treatment plants have already reported the increased incidence of 
antimicrobial products in the sludge that arrives for treatment (Carbajo, 2014). 
The presence of these chemicals makes the sanitation process more difficult, 
because as bacteria, mold and fungi become exposed to more of these 
ingredients, they subsequently become resistant to their action. 
CONCLUSION 
 
Estimates of overall paraben exposure are astounding and are not limited 
to adult populations. The potential health effects could begin with fetal exposure 
and continue into late adulthood with personal care product use. Though a direct 
cause and effect relationship between paraben exposure and specific diseases 
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have yet to be established, the biological impacts that parabens induce cannot 
be ignored. With further regulation and proactive manufacturing, paraben 
exposure can be reduced significantly, as personal care products are the main 
culprits. If significant reductions of paraben use in the manufacturing of PCPs 
can be accomplished, then the other areas of exposure should be negligible in 
perpetuating adverse health effects. There are many effective alternatives that 
can be used for the preservation of products used for human consumption and 
use. Manufacturers are already starting to lean away from paraben use and 
utilize some of these alternatives; however, more universal regulations should be 
put into effect in order to reduce overall paraben exposure as soon as possible. 
PROPOSAL FOR FUTURE RESEARCH 
 
Firstly, a better understanding of the direct health effects of paraben 
exposure must be established. Given the alarm surrounding the findings of intact 
parabens in breast cancer tumors, future studies should confirm that healthy 
breast tissue that has not had a nearby tumor, does not contain similar 
concentration. This can be accomplished by examining healthy breast tissue of 
whole-body donors, (thus preventing the unneeded biopsy of healthy women), 
and comparing a significant number of sample concentrations to those previously 
described in breast tumor and surrounding tissue samples. Specific assays of 
methyl-, propyl-, butyl-, and ethylparabens should be conducted, as these esters 
are the most commonly documented in unhealthy tissue. Depending on the result 
of this analysis, we will have a clearer picture as to whether the parabens found 
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in the unhealthy breast samples, in fact are associated with carcinogenesis, or 
are incidental. Additionally, rodent studies that examine long-term, low-dose 
exposure that relates more similarly to human exposure methods, would also 
provide more insight as to the potential toxicity of parabens. However, again 
these studies will not be completely conclusive, as the metabolism of parabens in 
rodents and humans have proven to be significantly different. Regardless, 
studies along these lines will provide much greater insight to the effects of real-
life exposure. 
The use of plant essential oils for personal care product preservation is a 
promising alternative to the use of parabens. Therefore, additional investigation 
into specific concentrations of various EOs for different PCP formulations will 
give manufacturers guidelines as to how they can effectively preserve their 
products in a potentially safer fashion. Additionally, bioengineering studies have 
shown the potential of using biodegradable nanoparticles to stabilize personal 
care products (Frangville, 2012). These options should also be explored further 
for the potential for everyday manufacturing. 
Concerns regarding the ingestion of sodium benzoate and the propensity 
of obesity and complications of diabetes, should also be examined further. Long-
term monitoring of serum metabolites in conjunction with standard levels of NaB 
intake in both healthy and obese volunteers should get us closer to answers 
regarding these questions.  
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